Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Neoplasms
A listing of clinical trials currently looking for volunteers to enroll in Neoplasms studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Bessemer : Birmingham Hematology and Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Birmingham : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Birmingham : Birmingham Hematology and Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Birmingham : Urology Centers of Alabama, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Birmingham : University of Alabama at Birmingham
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Birmingham : 1200.75.10013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Birmingham : University Of Alabama at Birmingham
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Birmingham : University of Alabama at Birmingham
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Birmingham : University of Alabama at Birmingham
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Homewood : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Homewood : Urology Center of Alabama
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Mobile : USA Mitchell Cancer Institute
A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Mobile : USA Mitchell Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Mobile : Southern Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Alaska
Anchorage : Alaska Clinical Research Center, Llc
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Anchorage : Alaska Clinical Research Center, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Anchorage : Alaska Clinical Research Center, LLC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Anchorage : Alaska Regional Hospital
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Arizona
Chandler : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Chandler : New Horizons Women's Care, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Goodyear : Weatern Regional Medical Center / Cancer Treatment Centers of America
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Phoenix : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Phoenix : Arizona OB/GYN Affiliates, PC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
View More »
Phoenix : Precision Trials
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : BCG Oncology, PC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Phoenix : Barrow Neurological Institute, St. Joseph's Hospital and Medical Center
In Vivo Confocal Microscopy Tumor Atlas Study
Phoenix : HOPE Research Institute
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Scottsdale : Investigational Site Number 840002
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Scottsdale : Scottsdale Clinical Research Institute
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
Scottsdale :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Advanced Cancer
Scottsdale : Scottsdale Healthcare, Site #134
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Scottsdale : Mayo Clinic
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Scottsdale : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Scottsdale : Mayo Clinic Updated
A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Scottsdale :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
Scottsdale : Novartis Investigative Site
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Scottsdale : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Scottsdale : Investigational Site Number 840003
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Scottsdale :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Scottsdale : Mayo Clinic Arizona
Dose-escalation Study of Oral CX-4945
Scottsdale : Investigational Site
Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Scottsdale : Mayo Clinic in Arizona
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Scottsdale : Mayo Clinic Scottsdale
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Scottsdale : Pinnacle Oncology
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Scottsdale :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Scottsdale : Mayo Clinic Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
Safety Study of PLX108-01 in Patients With Solid Tumors
Scottsdale : Site Reference ID/Investigator# 64046
Study of ABT-700 in Subjects With Advanced Solid Tumors
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Scottsdale : TGen Clinical Research Services Updated
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Scottsdale :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Scottsdale : TGen Clinical Research Service
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
Scottsdale : Arizona TGen Clinical Research Services at Scottsdale Heathcare
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Scottsdale : Ramesh K. Ramanathan M.D.
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Scottsdale : Mayo Clinic - Scottsdale
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Scottsdale : Pinnacle Hematology Oncology
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
Scottsdale : Pinnacle Oncology Hematology
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Scottsdale :
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Tucson : Arizona Cancer Center
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Tucson : Arizona Institute of Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tucson : Arizona Oncology Associates, PC - HOPE
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tucson : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Tucson : Urology Associates of Southern Arizona
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Tucson : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Tucson : Visions Clinical Research - Tucson
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Tucson : Site Reference ID/Investigator# 53006
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
Tucson : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Tucson : Arizona Urologic Specialists Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Tucson : Desert Sun Clinical Research Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Tucson : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Tucson : Desert Sun Clinical Research, LLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Tucson : Desert Sun Gastroenterology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Tucson : Desert Sun Surgery Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Tucson : Arizona Clinical Research Center
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Tucson : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Tucson : Arizona Cancer Center
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Tucson : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Tucson : The University of Arizona Cancer Center
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
Tucson : Southern Arizona VA Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Tuscon : The University of Arizona Cancer Center
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Arkansas
Fayetteville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
Fayetteville : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Fayetteville : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Fayetteville : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Jonesboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
View More »
Jonesboro : 1200.75.10034 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Jonesboro : Clopton Clinic Hematology/Oncology
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Little Rock : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Rogers : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
California
Alhambra : 1200.75.10113 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Anaheim : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bakersfield : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Bakersfield : Comprehensive Blood and Cancer Center
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Bakersfield : Comprehensive Blood and Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
View More »
Berkeley : Alta Bates Summit Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Berkeley : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Bermuda Dunes : Desert Oasis Healthcare
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Beverly Hills : Research Site
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Beverly Hills : Tower Cancer Research Foundation
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Burbank : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Burbank : Urology Specialists of Southern California - Burbank Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Campbell : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Colton : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Corona : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Corona : Compassionate Cancer Care Medical Group, Inc.
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Downey : Southern California Oncology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Duarte : City of Hope National Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Duarte : Site Reference ID/Investigator# 23283 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Duarte : Site Reference ID/Investigator# 27743 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Duarte : City Of Hope National Medical Center
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Duarte : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Duarte : City of Hope National Medical Center
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Duarte : City of Hope Medical Center
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Encinitas : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Encinitas : cCare - California Cancer Associatesfor Research Excellence
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Encino : Urology Specialists of Southern California
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Encino : Urology Specialist of Southern California - Encino Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Fountain Valley : Robert A. Moss, M.D., F.A.C.P., Inc
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fountain Valley : 1200.75.10010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fresno : Cancer Care Associates
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Fullerton : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Fullerton : 1200.75.10112 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fullerton : Southern California Oncology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Glendora : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Highland : Beaver Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Indio : JFK Memorial Hospital
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
La Jolla : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
La Jolla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
La Jolla : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
La Jolla : The Rebecca and John Moores UCSD Cancer Center
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
La Jolla : Thornton Hospital
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
La Jolla : Moores UCSD Cancer Center
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
La Jolla : UCSD Medical Center - La Jolla
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
La Jolla : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
La Jolla : University of California, San Diego
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
La Jolla : Moores University of California San Diego Cancer Center
Safety and PK Study of RRx-001 in Cancer Subjects
La Jolla : University of California San Diego / Moores Cancer Center
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
La Mesa : Franklin D. Gaylis, M.D. Inc, dba MedResearch
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
La Mesa : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa : Grossmont Center for Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
La Mesa : Cancer Center Oncology Medical Group
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
La Mesa : TriWest Research Associates
NP2 Enkephalin For Treatment of Intractable Cancer Pain
La Verne : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Laguna Hills : South Orange County Medical Research Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Loma Linda : Investigational Site Number 840013 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Long Beach : 1200.75.10104 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Long Beach : VA Hospital
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Los Angeles : University of California
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Los Angeles : Investigational Site Number 840004
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Los Angeles : Novartis Investigative Site
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Los Angeles : Cedars-Sinai Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : University of California Los Angeles
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : USC Norris Comprehensive Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : USC / Norris Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Los Angeles : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Los Angeles : Usc/Norris Comprehensive Cancer Center
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
Los Angeles : Childrens Hospital Los Angeles
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Los Angeles : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Los Angeles : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Los Angeles : Usc/Norris Comprehensive Cancer Center
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Los Angeles : Cedars-Sinai Medical Center
Combination Trial MSC1936369B With Temsirolimus
Los Angeles :
Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations
Los Angeles : American Institute of Research Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Los Angeles : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Los Angeles : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Los Angeles : 1200.75.10004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Los Angeles : Healthcare Partners Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Los Angeles : White Memorial Medical Center
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Los Angeles : University of Southern California, Norris Comprehensive Cancer Center Updated
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
Los Angeles : UCLA Jonsson Comprehensive Cancer Center
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Los Angeles : UCLA
Safety Study of PLX108-01 in Patients With Solid Tumors
Los Angeles : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Los Angeles : USC / Norris Comprehensive Cancer Center
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Los Angeles : Keck Hospital of USC
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Los Angeles : LAC + USC Medical Center
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Los Angeles :
Sorafenib Long Term Extension Program (STEP)
Los Angeles : USC Norris Comprehensive Cancer Center
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Los Angeles : Norris Comprehensive Cancer Center Updated
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Los Angeles : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Los Gatos : Bay Area Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Lynwood : Southern California Oncology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Marina del Rey : Prostate Oncology Speciality Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marina del Rey :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Mission Hills : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Mission Hills : Facey Medical Foundation
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Montclair : REMEK Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Montebello : 1200.75.10042 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Monterey : Monterey Bay GI Consultants Medical Group & Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Monterey Park : Furtura Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Murrieta : Tri Valley Urology Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Newport Beach : Gynecologic Oncology Associates
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
Newport Beach : Investigational Site Number 1526
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oakland : Hematology Oncology Associates
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Orange : Hematology-Oncology Medical Group of Orange County, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : Medical Oncology Care Associates (MOCA)
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : The Center for Cancer Prevention and Treatment, St. Joseph Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Orange : Chao Family Comprehensive Cancer Center
Study of Cabazitaxel Plus Bavituximab as Second-line Chemotherapy for Patients With Castration-resistant Prostate Cancer
Orange : University of California Irvine Medical Center
TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Orange : University of California Irvine
Tracking Renal Tumors After Cryoablation Evaluation
Oxnard : PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Oxnard : Diverse Research Solutions
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Palm Springs : Desert Oasis Healthcare
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Palm Springs : Desert Regional Medical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Pasadena : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pasadena : Huntington Memorial Hospital/Hill Breast Center
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Pasadena : UCLA Pasadena Oncology
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Pasadena : South Pasadena Cancer Center
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Pleasant Hill : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Pomona : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rancho Cucamonga : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rancho Cucamonga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Rancho Mirage : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Rancho Mirage : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Rancho Mirage : Hope Square Surgical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Redondo : Cancer Care Associates
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Redondo Beach : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Redondo Beach : 1200.75.10109 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Roseville : Sutter Roseville Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sacramento : Call for Information (Investigational Site 0006)
A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)
Sacramento : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Sacramento : Radiological Associates of Sacramento
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Sacramento : Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sacramento : Sutter Memorial Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sacramento : University of California Davis Cancer Center
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Sacramento : University of California at Davis
Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer
San Bernardino : San Bernardino Urological Associates
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
San Diego : University of California, San Diego: Moores Cancer Center, Site #099
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
San Diego : San Diego Clinical Trials
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
San Diego : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
San Diego : UCSD Medical Center
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
San Diego : Medical Oncology Associates - SD
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
San Diego : Sharp Rees-Stealy
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
San Diego : UCSD Medical Center - Hillcrest
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
San Diego : San Diego Clinical Trials Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
San Diego : Sharp Rees-Stealy Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
San Diego : UCSD Moores Cancer Research Institute
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
San Diego : Sharp-Rees-Stealy Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
San Diego : San Diego Pacific Oncology & Hematology Assoc Inc.
Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
San Diego : Innovative Research Center of California
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
San Francisco : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
San Francisco : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
San Francisco : UCSF
Bone Graft Materials Observational Registry
San Francisco : University of California San Francisco
ChemoFx® PRO - A Post-Market Data Collection Study
San Francisco : Investigational Site Number 840005
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
San Francisco : GSK Investigational Site
Dose-Escalation Study of GSK2126458
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
San Francisco : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
San Francisco : Research Site
Panitumumab Pediatric Study
San Francisco : Investigational Site Number 840001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
San Francisco : Investigational Site Number 840014 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
San Francisco : Call for Information (Investigational Site 0003)
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
San Jose : San Jose Women's Medical Group
ChemoFx® PRO - A Post-Market Data Collection Study
Santa Ana : Edward Alexson, MD, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Santa Barbara : 1200.75.10103 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Barbara : 1200.75.10106 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Barbara : Sansum Clinic
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Santa Barbara : Sansum Clinic
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Santa Barbara : Santa Barbara Hematology Oncology Medical Group, Inc.
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Santa Maria : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santa Maria : 1200.75.10102 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Maria : Central Coast Medical Oncology Corporation
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Santa Monica : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
Santa Monica : Premiere Oncology, A Medical Corporation Updated
A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
Santa Monica : Southern California Medical Gastroenterology Group, Inc Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Santa Monica : Santa Monica Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Santa Monica : UCLA Hematology-Oncology Santa Monica
Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Santa Monica : UCLA Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Santa Monica : Sarcoma Oncology Center
Safety Study of Sterile Compound c31510 for Injection to Subjects With Solid Tumors
Santa Monica : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Santa Monica : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Santa Monica : Premiere Oncology
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Santa Monica : UCLA Hematology-Oncology
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Santa Monica :
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Sherman Oaks : Women's Cancer Center Sherman Oaks
ChemoFx® PRO - A Post-Market Data Collection Study
Stanford : Stanford University School of Medicine
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Stanford : Stanford University School of Medicine
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Stanford : Stanford University School of Medicine
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Stanford : Stanford University School of Medicine
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Stockton : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sylmar : 1200.75.10107 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Tarzana : West Coast Clinical Research Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Torrance : GOA Torrance Memorial
ChemoFx® PRO - A Post-Market Data Collection Study
Torrance : Urology Specialists of Southern California - Torrance Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Torrance : Health Care Partners Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Torrance : South Bay Gastroenterology Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Valencia : UCLA Cancer Center-Valencia
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
West Covina : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
West Hollywood : James R. Berenson MD, Incorporated
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Westlake Village : UCLA Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Whittier : 1200.75.10039 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Yorba Linda : Southern California Oncology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Colorado
Aurora : University of Colorado
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Aurora : University of Colorado Cancer Center
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Aurora : University of Colorado Hospital, Site #015
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Aurora : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Aurora : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
View More »
Aurora : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Aurora : Children's Hospital Colorado
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Aurora :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Aurora : University of Colorado Denver
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Aurora : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Aurora : University of Colorado Health Science Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Aurora : University of Colorado Denver
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Aurora : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Aurora : Research Site
Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours
Aurora : University of Colorado Cancer Center Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Aurora :
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Boulder : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Colorado Springs : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : Rose Breast Center
A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
Denver : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : The Urology Center of Colorado
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : The Urology Center of Colorado
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Denver : The Urology Center of Colorado
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Denver : The Urology Center of Colorado Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Denver : Genitourinary Surgical Consultants, PC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Denver : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Denver : Rocky Mountain Cancer Centers - Denver Midtown
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Denver : The Urology Center of Colorado
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Denver : Kaiser Permanente
Tracking Renal Tumors After Cryoablation Evaluation
Englewood : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Englewood : Urology Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Fort Collins : Front Range Cancer Specialists
Dose-escalation Study of Oral CX-4945
Golden : Western Oncology/Hematology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lakewood : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Littleton : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lone Tree : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Longmont : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Loveland : Front Range Cancer Specialists
Dose-escalation Study of Oral CX-4945
Parker : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pueblo : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Thornton : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Connecticut
Bridgeport : Gastroenterology Associates of Fairfield County
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Fairfield : Gastroenterology Associates of Fairfield County
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Farmington : University of Connecticut Health Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Middlebury : Connecticut Clinical Research Center, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
New Britain : Grove Hill Medical Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
View More »
New Haven : Yale University Comprehensive Cancer Center
A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer
New Haven : Yale University, Site #033
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
New Haven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
New Haven : Yale Comprehensive Cancer Center
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
New Haven :
Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations
New Haven : Yale University, Comprehensive Cancer Center
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
New Haven :
Sorafenib Long Term Extension Program (STEP)
New Haven : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Norwalk : Norwalk Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Norwich : Eastern Connecticut Hematology and Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Southington : 1200.75.10041 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Stamford : Medical Oncology Hematology, Stamford Hospital
MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Torrington : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Delaware
Newark : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Newark : Christiana Hospital
Breath Test for Early Detection of Lung Cancer
Newark : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Florida
Aventura : South Florida Medical Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Aventura : Mount Sinai Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Aventura : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Boca Raton : South Florida Center for Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Boynton Beach : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
View More »
Boynton Beach : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Boynton Beach : Visions Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Boynton Beach : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Boynton Beach : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bradenton : Manatee Medical Research Institute, LLC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Brooksville : Pasco Hernando Oncology Associates, P.A.
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Clearwater : West Coast Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Coral Gables : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Coral Gables : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Delray Beach : Comprehensive Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Lauderdale : Holy Cross Hospital Bienes Comprehensive Cancer Center
A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Fort Lauderdale : Caruso and Gates MDs PA
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Myers : Florida Urology Physicians
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Fort Myers : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Fort Myers : Florida Cancer Specialists (Summerlin)
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Fort Myers : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Fort Myers : Florida Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Myers : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Fort Myers :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Ft. Lauderdale : 1200.75.10028 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ft. Myers : Florida Cancer Specialists
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Hialeah : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hialeah : Urological Research Network Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Holiday : 1200.75.10029 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hudson : Florida Cancer Specialists, PL
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
Jacksonville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Jacksonville : Mayo Clinic
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Jacksonville : Mayo Clinic Florida
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Jacksonville : Investigational Site Number 840016 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Lake Worth : Altus Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Lake Worth : Medical Specialist of Palm Beaches
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Lakeland : Lakeland Regional Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Lakeland : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Melbourne : MIMA Century Research Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Miami : Advanced Medical Specialties
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Miami : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Miami : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Miami : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Miami : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Miami : Miami Research Associates Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Miami : University of Miami Sylvester Comprehensive Cancer Center
Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
Miami : Miami Research Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Miami : Advanced Pharma CR
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Miami Beach : Mount Sinai Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Miami Beach : Mount Sinai Comprehensive Cancer Center
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
New Port Richey : Florida Cancer Specialists, PL
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Port Richey : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Ocala : Ocala Oncology Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Ocala : Ocala Oncology Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Ocala : Urology Health Team, PLLC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Ocala : Ocala Oncology
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Orlando : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Orlando : M.D. Anderson Cancer Center Orlando
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Orlando : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Orlando : MD Anderson Cancer Center
Breath Test for Early Detection of Lung Cancer
Pembroke Pines : Gynecologic Oncology Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Plantation : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Plantation : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Port St. Lucie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sarasota : Florida Cancer Specialists
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Sarasota : Call for Information (Investigational Site 0010)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Sarasota : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Sarasota : Sarasota Memorial Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
South Miami : South Miami Gynecologic Oncology Group
ChemoFx® PRO - A Post-Market Data Collection Study
South Miami : Miami Research Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
St. Petersberg : Pinellas Urology, Inc.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Stuart : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tampa : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Tampa : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Tampa : H. Lee Moffitt Cancer Center and Research Institute
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Tampa : Call for Information (Investigational Site 0002)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Tampa : Moffitt Cancer Center
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Tampa : Moffitt Cancer Center & Research Institute Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Tampa : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Tampa : Moffitt Cancer Center Updated
Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
Tampa : Updated
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Tampa : Moffitt Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Tampa : Call for Information (Investigational Site 0007)
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Tampa : Moffitt Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Tavares : 1200.75.10003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Titusville : Space Coast Medical Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Trinity : Advanced Research Institute, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
West Palm Beach : Palm Beach Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
West Palm Beach : Palm Beach Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
West Palm Beach : Hal Bashein, DO Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Georgia
Savannah : Memorial Health University Medical Center
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer COG ABTR01B1
View More »
Albany : Phoebe Putney Memorial Hospital
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Albany : Southwest Georgia Cancer Coalition
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Alpharetta : Georgia Cancer Specialists - Alpharetta
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Athens : Georgia Cancer Specialists - Athens
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Atlanta : Emory Winship Cancer Institute
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Atlanta : Emory University School of Medicine
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Atlanta : Georgia Cancer Specialists - Emory Midtown
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Midtown Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Peachtree Hematology-Oncology Consultants, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Atlanta : Emory University
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Atlanta : Emory University, Winship Cancer Institute
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Atlanta : Emory University Winship Cancer Institute
A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer
Atlanta : St. Joseph's Hospital - Resurgeons Orthopedics
Bone Graft Materials Observational Registry
Atlanta : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Atlanta : Emory Crawford Long Hospital
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Grady Memorial Hospital
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Winship Cancer Institute of Emory University
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Atlanta : Emory University Winship Cancer
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Atlanta : Atlanta Gastroenterology
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Atlanta : Atlanta Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Atlanta : Emory University
Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Atlanta : Emory University
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Atlanta : Emory University Winship Cancer Institute
Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Atlanta : Emory University Winship Cancer Institute Updated
Re-expression of ER in Triple Negative Breast Cancers
Atlanta : Emory University
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Atlanta : Emory University
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Atlanta : Emory University Winship Cancer Institute
Study of Arsenic Trioxide in Small Cell Lung Cancer
Atlanta : Emory University Winship Cancer Institute
Study of Everolimus (RAD001)in Combination With Lenalidomide
Atlanta : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Atlanta : Emory University Hospital
Study of MLN4924 in Adult Patients With Nonhematologic Malignancies
Atlanta : Winship Cancer Institute
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Atlanta : Emory University Winship Cancer Institute
Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
Atlanta : Emory University Winship Cancer Institute
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Augusta : Augusta Oncology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Augusta : Investigational Site Number 1239
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Blakely : Primary Care of Southwest Georgia
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Columbus : John B. Amos Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dawson : Albany Area Primary Health Care Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Decatur : Georgia Cancer Specialists - Stemmer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Douglasville : Atlanta Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Dublin : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Fayetteville : Georgia Cancer Specialists - Fayetteville
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Hiram : Atlanta Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Lawrenceville : 1200.75.10105 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Macon : Georgia Cancer Specialists - Macon
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Macon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Marietta : Georgia Cancer Specialists - Kennestone
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Marietta : Urology Enterprises
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Marietta : Atlanta Gastroenterology Associates Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Marietta : Atlanta Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Newnan : Better Health Clinical Research Inc
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Riverdale : Southeastern Gynecologic Oncology, LLC
ChemoFx® PRO - A Post-Market Data Collection Study
Riverdale : Southern Regional Medical Center
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
Rome : Harbin Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sandy Springs : Georgia Cancer Specialists - Northside
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Savannah : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Savannah : Memorial Health University Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Stockbridge : Georgia Cancer Specialists - Stockbridge
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stockbridge : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Valdosta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Hawaii
Honolulu : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Honolulu : The Queens' Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Idaho
Illinois
Arlington Heights : NCH Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Centralia : University Hematology Oncology, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Champaign : Christie Clinic
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Chicago :
A Dose-escalation Study in Subjects With Advanced Malignancies
Chicago : University of Chicago Medical Center, Site #001
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
View More »
Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Chicago : Site Reference ID/Investigator# 23284 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Chicago : Robert Lurie Comprehensive Cancer Center of Northwestern University
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Chicago : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Chicago :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Chicago : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Chicago : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Chicago : Site Reference ID/Investigator# 26525
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Chicago : Center for Women
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Chicago : Rush University
ChemoFx® PRO - A Post-Market Data Collection Study
Chicago : Northwestern Medicine Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Chicago : University of Chicago Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Chicago : Northwestern Memorial Hospital Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Chicago : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Chicago : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Chicago : University of Illinois at Chicago
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Jesse Brown VA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Rush University Gastroenterologists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Stroger Cook County
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Jesse Brown VAMC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Chicago : Northwestern University
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Chicago : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Chicago :
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Decatur : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Decatur : Investigational Site Number 840017 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Evanston : NorthShore Medical Group
ChemoFx® PRO - A Post-Market Data Collection Study
Evanston : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Galesburg : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Glenview : Uropartners
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Glenview : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Harvey : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hines : VA Hospital
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Joliet : Joliet Oncology-Hematology Associates, Ltd.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Joliet : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Maywood : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Maywood : Loyola University, Cardinal Bernardin Cancer Center
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Maywood : Loyola University Medical Center
Umbilical Cord Transplantation for the Elderly Population
Melrose Park : Uropartners/RMD Clinical Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Melrose Park : UroPartners/RMD Clinical Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Melrose Park : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Naperville : DuPage Medical Group
Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Niles : Oncology Specialists, S.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Niles : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Oak Lawn : Southwest Gastroenterology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Park Ridge : Oncology Specialists, S.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Peoria : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Quincy : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Rockford : Rockford Gastroenterology Associates, LTD
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Skokie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Skokie : 1200.75.10031 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Springfield :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Springfield : Southern Illinois University School of Medicine
A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Urbana : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Zion : Midwestern Regional Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Indiana
Anderson : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Avon : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Carmel : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Evansville : Deaconess Clinic, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Evansville : Global Scientific Innovations
NP2 Enkephalin For Treatment of Intractable Cancer Pain
View More »
Fishers : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Fort Wayne : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Greenfield : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Indianapolis : Indiana University Cancer Center
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Indianapolis : Indiana University Simon Cancer Center
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Indianapolis : ImClone Investigational Site
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Indianapolis : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Indianapolis : Indiana University
ChemoFx® PRO - A Post-Market Data Collection Study
Indianapolis :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Indianapolis : Community Regional Cancer Center-Community Hospital North
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Indianapolis : Quality Oncology Care, Inc.
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Indianapolis : Roudebush VA Medical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Indianapolis : IUPUI
Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Indianapolis : Indiana University Cancer Center
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Indianapolis : Indiana University Simon Cancer Center Updated
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Indianapolis : Indiana University Simon Cancer Center
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Jeffersonville : Metropolitan Urology Clinical Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jeffersonville : Metropolitan Urology Clinical Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Jeffersonville : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Lafayette : Horizon Oncology Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Lafayette :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Lafayette : Horizon Oncology Research, Inc.
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Martinsville : Morgan Hospital and Medical Center
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
New Albany : 1200.75.10025 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Terre Haute : 1200.75.10108 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Iowa
Ames : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Ames : McFarland Clinic
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Cedar Rapids : Physician's Clinic of Iowa, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cedar Rapids : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Cedar Rapids : Iowa Blood and Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
View More »
Clive : Iowa Digestive Disease Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Des Moines : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Iowa City : University of Iowa Hospitals and Clinics
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Iowa City : University of Iowa Hospitals and Clinics
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Iowa City : Holden Comprehensive Cancer Center
Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
Sioux City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Sioux City : Siouxland Hematology Oncology Associates
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Waterloo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Waterloo : 1200.75.10020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
West Desmoines :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Kansas
Fairway : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Kansas City :
A Study of RO5045337 in Patients With Solid Tumors
Kansas City : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Kansas City : University of Kansas Medical Center
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Overland Park : Kansas City Urology Care, P.A. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
View More »
Westwood : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Wichita : Cancer Center of Kansas
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Wichita : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Wichita : Cancer Center of Kansas
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Wichita : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Kentucky
Hazard : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Lexington : University of Kentucky
Tracking Renal Tumors After Cryoablation Evaluation
Louisville : Owlsey Brown Frazier Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Louisville : James Graham Brown Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Louisville : University of Louisville James Brown Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
View More »
Paducah : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Paducah : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Paducah : Investigational Site Number 840003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Paducah : Investigational Site Number 840002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Louisiana
Alexandria : Hematology Oncology Life Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Bastrop : Gastroenterology & Nutritional Medical Services
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Bastrop : Morehouse General Hospital
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Baton Rouge : Gastroenterology Associates
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Baton Rouge : Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
View More »
Baton Rouge : Investigational Site Number 840013 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Covington : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Covington : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Covington : Women's Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Metairie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Metairie : New Orleans Research Institue Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Metairie : New Orleans Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Metairie : Investigational Site Number 840003 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Monroe : Delta Research Partners, LLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New Orleans : Tulane University Health Sciences Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Orleans : Ochsner Clinic Foundation
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
New Orleans : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New Orleans : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
New Orleans : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
New Orleans : 1200.75.10019 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New Orleans : Tulane University Medical School
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer
New Orleans :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Shreveport : Regional Urology
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Shreveport : CHRISTUS Schumpert Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Shreveport : Louisiana Research Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Shreveport : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Maine
Lewiston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Scarborough : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Maryland
Baltimore :
A Dose-escalation Study in Subjects With Advanced Malignancies
Baltimore : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Baltimore : Site Reference ID/Investigator# 54056
A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
Baltimore : University of MD Greenbaum Cancer Center
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
A Study of of MORAb-004 in Subjects With Solid Tumors
View More »
Baltimore : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Baltimore : The Sidney Kimmel Comprehensive Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer
Baltimore : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Baltimore : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Baltimore : Sinai Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Baltimore : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors
Baltimore : University of Maryland Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Baltimore : Chesapeake Urology Research Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Baltimore : University of Maryland & Baltimore VA medical centre
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors
Baltimore : Digestive Disease Associates, PA
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Baltimore : University of Maryland Greenebaum Cancer Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Baltimore : Investigational Site Number 840019 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Baltimore :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Baltimore : Weinberg Cancer Institution at Franklin Square
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Baltimore : Saint Agnes Healthcare
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Bethesda : National Cancer Institute - Center for Cancer Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bethesda : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bethesda : 1200.75.10038 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bethesda : Center for Cancer and Blood Disorders
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Bethesda : NCI, CCR
Open Label Study to Evaluate the Safety and Tolerability of GI-6301 a Vaccine Consisting of Whole Heat-Killed Recombitant Yeast Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors
Bethesda : National Cancer Institute Center for Cancer Research, Medical Oncology Branch
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Bethesda : Bethesda Naval Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Chevy Chase : Chevy Chase Clinical Research
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chevy Chase : Metropolitan Gastroenterology Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Columbia : Columbia Medical Practice Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Columbia : Columbia Medical Practice
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Cumberland : Corbin Clinical Resources Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Elkridge : Centennial Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Frederick : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Glen Burnie : Chesapeake Urology Research Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Greenbelt : Myron I Murdock MD LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Greenbelt : Myron I. Murdock MD, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Greenbelt : Myron I. Murdock, MD, LLC
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Greenbelt : Myron I. Murdock, MD, LLC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Kensignton :
A Study of RO5045337 in Patients With Solid Tumors
Rockville : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Salisbury : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Silver Springs : Women's Health Specialists
ChemoFx® PRO - A Post-Market Data Collection Study
Towson : Chesapeake Urology Research Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Massachusetts
Boston : Massachusetts General Hospital Cancer Center
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Boston : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
Boston : Mass General Hospital (MGH), Site #047
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Boston : Beth Israel Deaconess Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
View More »
Boston : Dana Farber Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Boston : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Boston : Dana Farber Cancer Institute
A Safety Study of Oral ZSTK474 in Patients With Cancer
Boston : Site Reference ID/Investigator# 41931
A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
Boston : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Boston : ImClone Investigational Site
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Boston : Dana Farber Cancer Institute (DFCI)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Boston : Beth Israel Deaconess Medical Center (BIDMC)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Boston : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Boston : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Boston : Dana Farber Cancer Institute
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Boston :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Boston : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Boston : Tufts-New England Medical Center
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Boston : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Boston : BWH
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Boston : Site Reference ID/Investigator# 58882
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Boston : Dana-Farber Cancer Inst
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Boston : Beth Israel Deaconess Medical Center`
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Massachusetts General Hospital
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Boston : Massachusetts General Hospital / Dana Farber Cancer Institute
E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)
Boston : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Boston : Beth Israel Deaconess Medical Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Dana-Farber Cancer Institute
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Boston : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Boston : Beth Israel Deaconess Medical Center
MSC2015103B in Solid Tumors
Boston : Dana-Farber Cancer Institute
MSC2015103B in Solid Tumors
Boston : Boston Medical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Boston : Investigational Site Number 840002
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Boston : Investigational Site Number 840001
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Boston : Beth Israel Deaconess Medical Center
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Boston : Dana-Farber Cancer Institute
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Boston : Dana-Farber Cancer Institute
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Boston : Investigational Site Number 840012 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Boston : Dana-Farber Cancer Institute
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Boston : Beth Israel Deaconess Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Dana Farber Cancer Institute
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Massachusetts General Hospital
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Boston : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Boston : Dana Farber Cancer Institute
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Boston : Beth Israel Deaconess Medical Center
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
Boston : Dana Farber Cancer Institute
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Massachusetts General Hospital Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Dana Farber Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Investigational Site Number 1133
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Boston : Dana Farber Cancer Institute
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Boston : Massachusetts General Hospital
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Boston : Massachusetts General Hospital
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Boston : Dana Farber Cancer Institute
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Brockton : Commonwealth Clinical Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Brockton : Commonwealth Clinical Studies PLLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
East Bridgewater : Commonwealth Clinical Studies PLLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Rockland : For Recruiting Locations in the US contact US Medical Information in
Combination Trial MSC1936369B With Temsirolimus
Watertown : Bay State Urologists Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Worcester : UMass Memorial Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Michigan
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
View More »
Ann Arbor : University of Michigan Cancer Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Ann Arbor : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Ann Arbor : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Ann Arbor : University of Michigan
Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone
Dearborn : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Detriot : Wayne State University Karmanos Cancer Institute
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Detroit : Karmanos Cancer Institute
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Detroit : Karmanos Cancer Institute
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Detroit :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Detroit : Karmanos Cancer Institute
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Detroit : Site Reference ID/Investigator# 19021
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Detroit : Karmanos Cancer Institute
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Detroit :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Detroit : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Detroit : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Detroit : Henry Ford Health System
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Detroit : Wayne State University Department of Oncology Karmanos Cancer Institute
A Study of DS-2248, in Subjects With Advanced Solid Tumors
Detroit : Novartis Investigative Site
A Study of Oral LGK974 in Patients With Melanoma and Lobular Breast Cancer
Detroit : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Detroit : Karmanos Cancer Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Detroit : Karmanos Cancer institute
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Detroit : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Detroit : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Detroit : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Detroit : Site Reference ID/Investigator# 62482
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
Detroit : Wayne State University
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Detroit : Henry Ford Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Detroit : Karmanos Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Detroit : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Detroit : Wayne State University, Division of Hematology/Oncology, Karmanos Cancer Institute
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Detroit : Henry Ford Medical Center
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
Detroit : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Detroit : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Detroit : Karmanos Cancer Institute
MSC2015103B in Solid Tumors
Detroit : Karmanos Cancer Institute
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Detroit : Karmanos Cancer Institute
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Detroit : Henry Ford Health System
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Detroit : Wayne State (Karmanos Cancer Institute)
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Detroit : Karmanos Cancer Institute
Safety Study of AB0024 in Patients With Advanced Solid Tumors
Detroit : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Detroit : Site Reference ID/Investigator# 57555
Study of ABT-700 in Subjects With Advanced Solid Tumors
Detroit : Karmanos Cancer Institute
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Detroit : Karmanos Cancer Institute
Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
Detroit : Karmanos Cancer Institute
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Detroit : Karmanos Cancer Institute
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Detroit : Wayne State University/Karmanos Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Detroit : Investigational Site Number 1326
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Detroit : Research Site
Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours
Detroit : Karmanos Cancer Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Detroit : Henry Ford Health System Protocol Review Committee Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Farmington Hills : Karmanos Cancer Institute at Farmington Hills
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Grand Rapids : Spectrum Health Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Grand Rapids : Gynecologic Oncology of West Michigan
ChemoFx® PRO - A Post-Market Data Collection Study
Grand Rapids : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lansing : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Southfield : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Southfield : PRESSD
Bone Graft Materials Observational Registry
St. Clair Shores : Michgan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Troy : Michigan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Troy : Center for Digestive Health
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Utica : Michigan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Warren : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Minnesota
Burnsville : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Coon Rapids : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Duluth : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Duluth : 1200.75.10005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Edina : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Fridley : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Maplewood : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minneapolis : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minneapolis : Research Site
Panitumumab Pediatric Study
Minneapolis : University of Minnesota Medical Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Minneapolis : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Rochester : Mayo Clinic Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Rochester : Call for Information (Investigational Site 0001)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 in Patients With Advanced Cancer
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study of LY2875358 in Patients With Advanced Cancer
Rochester : Mayo Clinic
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Rochester : Mayo Clinic
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Rochester : Mayo Clinic Rochester
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Rochester : Updated
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Rochester : Mayo Clinic Cancer Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Rochester : Investigational Site Number 840008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Rochester : Mayo Clinic
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Rochester : Pfizer Investigational Site
Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
Rochester : Investigational Site Number 840007 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Saint Cloud : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
St Louis Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
St. Louis Park : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
St. Paul : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Woodbury : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Mississippi
Jackson : Mississippi Oncology Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Southaven : University of Tennessee Cancer Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Missouri
Columbia : Investigational Site Number 840015 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Kansas City : Research Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Kansas City : Department of Veterans Affairs Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Saint Louis : Research Site
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Saint Louis : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Saint Louis : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Springfield : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
St Louis : Washington University
A Safety Study of Oral ZSTK474 in Patients With Cancer
St Louis : Washington University Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
St Louis : Investigational Site Number 840001 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
St. Louis : Siteman Cancer Center, Washington University School of Medicine
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
St. Louis :
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
St. Louis :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
St. Louis : Washington University School of Medicine Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Montana
Billings : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Billings : Billings Clinic Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Billings : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Great Falls : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Missoula : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Missoula : Montana Neuroscience Institute Foundation
Bone Graft Materials Observational Registry
Missoula : Montana Cancer Institute Foundation
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Nebraska
Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC / Southeast Nebraska Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lincoln : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Omaha : Urology Cancer Center and GU Research Network
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Omaha : GU Research Network, LLC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Omaha : Urology Cancer Center & GU Research Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Omaha : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Omaha : Nebraska Methodist Hospital
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Omaha : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Omaha : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Omaha : University of Nebraska
Tracking Renal Tumors After Cryoablation Evaluation
Nevada
Henderson : Comprehensive Cancer Centers of Nevada
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Henderson : Comprehensive Cancer Centers of Nevada
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Las Vegas : Comprehensive Cancer Centers of Nevada
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Las Vegas : Comprehensive Cancer Centers of Nevada
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
View More »
Las Vegas : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Las Vegas : Comprehensive Cancer Centers of Nevada
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Las Vegas : Comprehensive Cancer Centers of Nevada
Safety Study of PLX108-01 in Patients With Solid Tumors
Las Vegas : Comprehensive Cancer Centers of Nevada
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Las Vegas :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Reno : VA Sierra Nevada HealthCare System
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Reno : Digestive Health Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Reno : Advanced Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Reno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
New Hampshire
Dover : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Lebanon : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Lebanon : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New Jersey
Berkeley Heights : Summit Medical Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Berlin : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Denville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Egg Harbor Township : AGA Clinical Research Associates, LLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Hackensack : Research Site
AMG 319 Lymphoid Malignancy FIH
View More »
Hackensack : Hackensack University Medical Center
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Hackensack : Haceknasack University Medical Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Hackensack : Cancer Center at Hackensack University Medical Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Lawrenceville : Premier Urology Associates, LLC / AdvanceMed Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Morristown : Hematology-Oncology Associates of Northern NJ, PA; Carol G. Simon Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Morristown : Morristown Memorial Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Mt. Laurel : Delaware Valley Urology, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Mt. Laurel : Delaware Valley Urology, LLC Burlington Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
New Brunswick :
Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations
New Brunswick : Cancer Institute of New Jersey
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
New Brunswick : GSK Investigational Site
Dose-Escalation Study of GSK2126458
New Brunswick : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
New Brunswick : The Cancer Institute of New Jersey
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
New Brunswick : Cancer Institute of New Jersey
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Newark : Investigational Site Number 840009 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Newark : Investigational Site Number 840006 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Princeton : Bracco Diagnostics Inc.
SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
Princeton : Bracco Diagnostics Inc
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
Somerville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Teaneck : Holy Name Medical Center
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Teaneck : Gara M Sommers MD
ChemoFx® PRO - A Post-Market Data Collection Study
Teaneck : 1200.75.10002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Voorhees : Cooper Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Vorhees : Delaware Valley Urology Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
New Mexico
Albuquerque : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Albuquerque : New Mexico Oncology Hematology Consultants, LTD
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Albuquerque : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Santa Fe : New Mexico Cancer Care Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York
Albany : New York Oncology Hematology, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Albany : Women's Cancer Care Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Albany : The Capital Region Medical Research Foundation, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Albany : Albany Medical Center Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Albany : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
View More »
Albany : NYOH Albany Cancer Center at Patroon Creek
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Albany : Community Care Physicians, PC
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Atlantic Beach : St. John's Episcopal Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Binghamton : Binghamton Gastroenterology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Bronx : Albert Einstein Cancer Center at the Montefiore Medical Park
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bronx : Montefiore Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bronx : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Bronx : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Bronx : Montefiore Medical Center
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Bronx : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Bronx : Montefiore Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Bronx : Montefiore Medical Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Bronx : Eastchester Center for Cancer Care
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Bronx : Montefiore Medical Center
Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Bronx : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Brooklyn : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Buffalo : Zale P. Bernstein, MD, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Buffalo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Buffalo : Roswell Park Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Buffalo : Roswell Park Cancer Institute
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Cancer
Buffalo : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Buffalo :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Buffalo : Roswell Park Cancer Institute
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Buffalo : Roswell Park Cancer Institute
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
East Setaukey : North Shore Hematology/Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
East Syracuse : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Garden City : Accumed Research Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Garden City : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Great Neck : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Great Neck : Long Island Gastrointestinal Group
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Great Neck : Gastrointestinal Research Group
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Great Neck : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Lake Success : Monter Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Lake Success : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Lake Success : 1200.75.10044 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lake Success : North Shore University Hospital-Monter Cancer Center
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Manhasset : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Manhasset : North Shore University Hospital
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Manhassett : North Shore LIJ Health System
ChemoFx® PRO - A Post-Market Data Collection Study
New Hyde Park : North Shore University Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
New York : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
New York : Novartis Investigative Site
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
New York : Memorial Sloan-Kettering Cancer Center
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
New York : Columbia University Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
New York : University Urology Associates
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
New York : NYU Langone Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York : NYU Clinical Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York : University Urology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York :
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
New York : Site Reference ID/Investigator# 23282 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
New York : Memorial Sloan Kettering Cancer Center
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
New York : Weill Cornell Cancer Center
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
New York : Memorial Sloan-Kettering Cancer Center
A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours
New York : Memorial Sloan Kettering Cancer Center
A Study of of MORAb-004 in Subjects With Solid Tumors
New York :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
New York : Memorial Sloan Kettering Cancer Center
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
New York : Memorial Sloan Kettering Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer
New York : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
New York : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
New York : New York Downtown Hospital
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
New York : Mount Sinai
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
New York : Memorial Sloan Kettering Cancer Center
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
New York : New York University Medical Center
Breath Test for Early Detection of Lung Cancer
New York : Memorial Sloan-Kettering Cancer Center
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
New York : The Mount Sinai Medical Center
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
New York : Columbia University Medical Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
New York : University Urology Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
New York : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
New York :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
New York : 1200.75.10008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New York : 1200.75.10027 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New York : Mount Sinai School of Medicine
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
New York : Alpert Pavilion
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : Faculty Practice Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : GI Clinic
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : Internal Medicine Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : Mount Sinai School of Medicine
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : Practice Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New York : Research Site
Panitumumab Pediatric Study
New York : Memorial Sloan-Kettering Cancer Center
Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors
New York : Mount Sinai Medical Center
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
New York : Memorial Sloan Kettering Cancer Center
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
New York : NYU Cancer Center
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
New York : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Memorial Sloan-Kettering Cancer Center
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
New York : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
New York :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
New York : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
New York : Memorial Sloan-Kettering Cancer Center
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
New York : Memorial Sloan-Kettering Cancer Center
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
New York : Memorial Sloan-Kettering Cancer Center
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
New York : Columbia University
Tracking Renal Tumors After Cryoablation Evaluation
New York city : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Port Jefferson : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Poughkeepsie : Hudson Valley Urology, P.C.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Poughkeepsie : Premier Medical Group of the Hudson Valley
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Poughkeepsie : Premier Medical Group of the Hudson Valley Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Poughkeepsie : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Poughkeepsie : Premier Medical Group of the Hudson Valley
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Rochester : University of Rochester Medical Center, James P. Wilmot Cancer Center
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Rochester : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Staten Island : Staten Island Urological Research, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Staten Island : Staten Island Urological Research, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Staten Island : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Staten Island : Richmond University Medical Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Stony Brook : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Syracuse : Associated Medical Professionals of New York, PLLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Syracuse : Syracuse Orthopedic Specialists
Bone Graft Materials Observational Registry
North Carolina
Advance : Digestive Health Specialists, PA
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Asheville : Hope: A Women's Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Asheville : 1200.75.10110 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Asheville : Asheville Gastroenterology
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Asheville : Asheville Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
View More »
Asheville : Cancer Care of WNC
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Asheville : Allergy Partners of West North Carolina
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Boone : MediSpect
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Burlington : Alamance Regional Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Cary : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cary : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Chapel Hill : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Chapel Hill : University of North Carolina - Chapel Hill
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Chapel Hill : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Chapel Hill : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Chapel Hill : UNC - Chapel Hill
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Chapel Hill : Updated
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Chapel Hill : University of North Carolina
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Chapel Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Chapell Hill : University of North Carolina at Chapel Hill
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
Charlotte : Presbyterian Hospital Center for Cancer Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Charlotte : Blumenthal Cancer Center - Main
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Charlotte : Carolinas Medical Center
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Charlotte : Carolinas Hematology-Oncology Associates
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Charlotte : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Charlotte : Blumenthal Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Charlotte : Presbyterian Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Charlotte : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Charlotte : Carolina Digestive Endoscopy Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Charlotte : Carolina Digestive Health Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Charlotte : Carolinas HealthCare System
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Concord : Northeast Urology Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Concord : Carolinas Medical Center- North East
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Concord : Gateway Surgery Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Concord : Carolina Digestive Health Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Davidson : Carolina Digestive Health Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Durham : Research Site
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Durham : Regional Cancer Care PA
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Durham : Duke University Medical Center - Duke South Clinics
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Durham : Regional Cancer Care, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Durham : Duke University Medical Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Durham : Research Site
AMG 319 Lymphoid Malignancy FIH
Durham : Novartis Investigative Site
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Durham : Duke University Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Durham : Duke University Medical Center
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Durham : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Durham : Duke Cancer Institute
Dose Escalation Study of Pazopanib Plus TH-302
Durham : Duke University Medical Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
Durham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Durham :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Durham : Duke University Medical Center
Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Durham : Duke University Medical Center
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Durham : Duke University Medical Center
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Durham : Duke University Medical Center
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
Durham : Site Reference ID/Investigator# 66111
Study of ABT-700 in Subjects With Advanced Solid Tumors
Durham : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Durham : Duke University Medical Center Pediatric Blood and Marrow Transplant
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Fayetteville : Cape Fear Valley Health System
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fayetteville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Fayetteville : Cumberland Research Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Gastonia : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Goldsboro : Southeast Medical Oncology Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Goldsboro : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Greensboro : Alliance Urology Specialists, PA
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Greensboro : The Moses Cone Regional Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Greenville : Leo W. Jenkins Cancer Center at ECU Medical School
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Harrisburg : Carolina Digestive Health Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
High Point : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Huntersville : Carolina BioOncology Institute, PLLC
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Huntersville : Carolina Digestive Endoscopy Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Kernersville : Digestive Health Specialists, PA
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
New Bern : Coastal Carolina Health Care, PA, dba New Bern Cancer Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Bern : New Bern Cancer Care, PA
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Pinehurst, : First Health of the Carolinas, Moore Regional Hospital
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Raleigh : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Raleigh : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Raleigh : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Raleigh : Wake Research Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Raleigh : Rex Cancer Center at Rex Hospital
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Raleigh :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Washington : Marion L. Shepard Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Wilmington : North Hanover Regional Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Wilmington : Hanover Medical Specialists
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Wilmington : New Hanover Regional Medical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Wilmington : Wilmington Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Winston Salem : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Winston Salem : University of Wake Forest Baptist Medical Center
Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Winston-Salem : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Winston-Salem : Digestive Health Specialists, PA
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Winston-Salem : Center for Clinical Research
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Winston-Salem : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
North Dakota
Bismarck : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Bismarck : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Fargo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Fargo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Ohio
Akron : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Canton : Gabrail Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Canton : 1200.75.10021 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Canton : Gabrail Cancer Center Research LLC
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Canton : Investigational Site Number 840002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Cincinnati : TriState Urologic Services PSC, Inc. dba TUG Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Cincinnati :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Cincinnati : University of Cincinnati
ChemoFx® PRO - A Post-Market Data Collection Study
Cincinnati : Investigational Site Number 840004
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Cincinnati : TriState Urologic Services PSC, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Cincinnati : Investigational Site Number 840002
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
Cincinnati : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Cincinnati : 1200.75.10023 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Cincinnati : Investigational Site Number 840007 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Cincinnati :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Cinncinati :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Cleveland : Research Site
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Cleveland : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Cleveland : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Cleveland : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Cleveland : Case Western Reserve University, University Hospitals of Cleveland
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic, Taussig Cancer Institute
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : University Hospitals of Cleveland
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
Cleveland :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Cleveland : Cleveland Clinic
The Study of Barrett's Esophagus: What Are the Factors of Progression
Columbus : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Columbus : Columbus Urology Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Columbus : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Columbus : Columbus Urology Research, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Columbus : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Columbus : OSU Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Columbus : Columbus Urology Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Columbus : Ohio State University Comprehensive Cancer Center - The James
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Columbus : The Ohio State University - Comprehensive Cancer Center
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Columbus : Investigational Site Number 1325
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Columbus : Ohio State University
Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Englewood : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Kettering : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Middletown : Signal Point Clinical research Center
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Middletown : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toedo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Oklahoma
Bethany : Parkhurst Research Organization, LLC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Oklahoma City : University of Oklahoma
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
Oklahoma City : University of Oklahoma Health Sciences Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oklahoma City : Oklahoma University
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Oklahoma city : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
View More »
Oklahoma City : Oklahoma University
A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Oklahoma City : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Oklahoma City : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Oklahoma City : Oklahoma Gynecologic Oncology Group
ChemoFx® PRO - A Post-Market Data Collection Study
Oklahoma City :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Notch Inhibitor in Advanced Cancer
Oklahoma City : Peggy and Charles Stephenson Oklahoma Cancer Center
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Oklahoma City : Oklahoma University Cancer Institute
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Oklahoma City : Peggy and Charles Stephens Oklahoma Cancer Center
Safety Study of X-82 in Patients With Advanced Solid Tumors
Oklahoma City : Oklahoma University
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Oklahoma City : Investigational Site Number 1434
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oklahoma City : Univ. Oklahoma Health Science Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Oregon
Bend : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eugene : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Eugene : Pain Research of Oregon
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Portland : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Portland : Providence Cancer Center Oncology and Hematology Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Portland : Providence Portland Cancer Center
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Portland : Oregon Health & Science University
Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
Portland : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Portland : Oregon Health & Science University
ChemoFx® PRO - A Post-Market Data Collection Study
Portland : Providence Cancer Center Oncology and Hematology Care
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Portland : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Portland : Northwest Gastroenterology Clinic, LLC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Portland : Northwest Gastroenterology Clinic, LLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Portland : Research Site
Panitumumab Pediatric Study
Portland : Oregon Health & Science University
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Portland : Oregon Health and Sciences University
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Cancer Center
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Portland Med Ctr
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Portland : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Portland : Oregon Health and Science University
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Springfield : Willamette Valley Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Tualatin : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tualatin : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Tualatin : Legacy Meridian Park Medical Center Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Pennsylvania
Abington : Call for Information (Investigational Site 0009)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Abington : Investigational Site Number 1132
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Allentown : Breast Care Specialist, PC
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Bala Cynwyd : Urologic Consultants of SE PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bala Cynwyd : Urology Consultants of Southeastern Pennsylvania
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
View More »
Bala Cynwyd : Urologic Consultants of SE PA Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Bethlehem : Investigational Site Number 840010 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Bryn Mawr : Urology Health Specialists, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bryn Mawr : Urology Health Specialists, LLC Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Carnegie : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Danville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Indiana : Ilumina Clinical Associates Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Lancaster : Urological Associates Of Lancaster
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Lancaster : Urological Associates of Lancaster
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lancaster : Urological Associates of Lancaster
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Lancaster : Urological Associates of Lancaster Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Lancaster : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Lancaster : Regional Gastroenterology Associates of Lancaster, LTD
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Lemoyne : 1200.75.10018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Perkasie : Main Line Gastroenterology Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Perkasie : Main Line Gastroenterology
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Philadelphia :
A Dose-escalation Study in Subjects With Advanced Malignancies
Philadelphia : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Philadelphia :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Philadelphia : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Philadelphia : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Philadelphia : Fox Chase Cancer Center
A Safety Study of Oral ZSTK474 in Patients With Cancer
Philadelphia : Site Reference ID/Investigator# 23286 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Philadelphia : Thomas Jefferson University Hospital
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Philadelphia : University of Pennsylvania Abramson Cancer Center
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Philadelphia :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Philadelphia : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Philadelphia :
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Philadelphia : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Philadelphia : Hospital of the University of Pennsylvania Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Philadelphia : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Philadelphia : PGC Endoscopy Center Inc.
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Philadelphia : Fox Chase Cancer Center
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Philadelphia :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Philadelphia : Pennsylvania Oncology Hematology Associates
Safety Study of PLX108-01 in Patients With Solid Tumors
Philadelphia : Hospital Of The University Of Pennsylvania
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Philadelphia :
Sorafenib Long Term Extension Program (STEP)
Philadelphia : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Philadelphia : Fox Chase Cancer Center
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Philadelphia : Investigational Site Number 1134
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Philadelphia : Research Site
Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours
Philadelphia : Fox Chase Cancer Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Philadelphia : Fox Chase Cancer Center Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Philadelphia : Pennsylvania Oncology
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Pittsburgh : University of Pittsburgh
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Pittsburgh :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
Pittsburgh : Pittsburgh Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Pittsburgh : University of Pittsburgh Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Pittsburgh : Triangle Urological Group Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Pittsburgh : UPMC Shadyside Radiation Oncology
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Pittsburgh : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Pittsburgh : Hillman Cancer Center
Pilot Study for Locally Advanced Head and Neck Cancer
Pittsburgh : Allegheny General Hospital
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Pittsburgh, : University of Pittsburgh
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Rockledge : Fox Chase Cancer Center
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
Sayre : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
State College : Mount Nittany Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
State College : Mount Nittany Physician Group Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
West Reading : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
West Reading : Reading Hospital and Medical Center
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Willow Grove : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Rhode Island
Cranston : Hematology Oncology Associatesof Rhode Island
NP2 Enkephalin For Treatment of Intractable Cancer Pain
East Providence : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
East Providence : Pharma Resource Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Providence : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Providence : Investigational Site Number 1142
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
View More »
Providence : Bayside Endoscopy Center
Third Eye Retroscope Randomized Clinical Evaluation
South Carolina
Charleston : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Charleston : Charleston Hematology Oncology Associates, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Charleston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Charleston : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleston : Medical University of South Carolina (MUSC)
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
View More »
Charleston : Medical University of South Carolina
Tracking Renal Tumors After Cryoablation Evaluation
Columbia : South Carolina Oncology Associates, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Columbia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Columbia : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Greenville : Call for Information (Investigational Site 0011)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Greenville : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Greenville : Cancer Center of the Carolinas
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Greenville : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Mrytle Beach : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Mt. Pleasant : Coastal Carolina Research Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Myrtle Beach : Carolina Urologic Research Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Myrtle Beach : Carolina Urologic Research Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Myrtle Beach : Carolina Urologic Research Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Myrtle Beach : Carolina Urologic Research Center
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Myrtle Beach : Carolina Urologic Research Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Myrtle Beach : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Myrtle Beach : Grand Strand Urology
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
West Columbia : Lexington Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
South Dakota
Rapid City : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sioux Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Sioux Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Sioux Falls : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sioux Falls : Sandford USD Health System
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Watertown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tennessee
Bartlett : University of Tennessee Cancer Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Chattanooga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Chattanooga : Chattanooga Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Chattanooga : Chattanooga's Program in Women's Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Germantown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Germantown : Gastro One
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Germantown : Gastro One
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Germantown : University of Tennessee Cancer Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Kingsport : Gastroenterology Associates of Clinical Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Knoxville : Thomas W. McDonald MD
ChemoFx® PRO - A Post-Market Data Collection Study
Knoxville : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Memphis : The West Clinic
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Memphis : The West Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Memphis : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Memphis : The West Clinic
A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
Memphis : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Memphis : St. Jude Children's Research Hospital
A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
Memphis : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Memphis : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Memphis : University of Tennessee Cancer Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Memphis : Call for Information (Investigational Site 0005)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Memphis : The West Clinic
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Nashville : Sarah Cannon Cancer Research Institute
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
Nashville :
A Dose-escalation Study in Subjects With Advanced Malignancies
Nashville : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Advanced Cancer
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Patients With Advanced Cancer
Nashville : Sarah Cannon Research Institute
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Nashville : Urology Associates, PC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Nashville : Sarah Cannon Research Institute
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
Nashville : Vanderbilt University Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Nashville : Urology Associates, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Nashville : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Nashville :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Nashville : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Nashville : Sarah Cannon Research Institute
A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Nashville : Sarah Cannon Research Institute Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Nashville :
A Study of GDC-0575 Alone And in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Nashville : Sarah Cannon Research Institute (SCRI)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Nashville : Investigational Site Number 840002
A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Nashville : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Nashville : Urology Associates, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Nashville : Sarah Cannon Research Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Nashville : Tennessee Oncology
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Nashville : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Nashville : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Nashville : Tennessee Oncology, PLLC
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Nashville : Novartis Investigative Site
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Nashville : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Nashville : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Nashville : Investigational Site Number 840001
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Nashville :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Nashville :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Nashville : The Sarah Cannon Research Institute
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Nashville : Vanderbilt University Medical Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Nashville : Vanderbilt University
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Nashville : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Notch Inhibitor in Advanced Cancer
Nashville : Sarah Cannon Research - Drug Development Unit
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Nashville : Investigational Site Number 840003
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Nashville : The Sarah Cannon Research Institute
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Nashville : Tennessee Oncology, PLLC
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Nashville : Sarah Cannon Research Institute
Safety and PK Study of RRx-001 in Cancer Subjects
Nashville : Vanderbilt-Ingram Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Nashville : Sarah Cannon Research Institute
Safety Study of X-82 in Patients With Advanced Solid Tumors
Nashville : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Nashville : Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Nashville : Sarah Cannon Research Institute
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Nashville : Jeffrey R. Infante
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Nashville : Tennessee Oncology
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
Nashville : Sarah Cannon Research Institute
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Nashville : Vanderbilt University
Tracking Renal Tumors After Cryoablation Evaluation
Nashville : Monroe Carell Jr. Children's Hospital at Vanderbilt
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Nashville :
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Nashville, : The Vanderbilt-Ingram Cancer Center
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Texas
Abilene : Hendrick Medical Center / Hendrick Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Abilene : Texas Cancer Center Abilene, Texas Oncology P.A.
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Amarillo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Arlington : Arlington Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Arlington : Texas Oncology - Arlington North
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Arlington : Texas Oncology - Arlington South
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Arlington : Urology Associates of North Texas Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Austin : Texas Oncology - Austin Midtown
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Texas Oncology - Austin North
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Texas Oncolocy - South Austin
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Professional Quality Research, Inc. Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Austin : Professional Quality Research, Inc.
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Autstin : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Beaumont : Texas Oncology - Beaumont, Mamie McFaddin Ward Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bedford : Texas Oncology, P.A.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Cedar Park : Texas Oncology - Cedar Park
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Corpus Christi : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Corpus Christi : 1200.75.10037 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
Dallas : Texas Oncology, P.A.
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Dallas : Urology Clinics of North Texas
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Dallas : Texas Oncology - Baylor Charles A. Sammons Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dallas : Texas Oncology - Dallas Presbyterian Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Dallas : Mary Crowley Cancer Research Centers - Medical City Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Dallas : North Texas Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Dallas : UT Southwestern Medical Center - Simmons Cancer Center
Clinical Trial of ARQ 761 in Advanced Solid Tumors
Dallas : Urology Clinics of North Texas, PA Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Dallas : Mary Crowley Cancer Center
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Dallas : Mary Crowley Cancer Research Center
Phase 1 Study of ONT-10 in Patients With Solid Tumors
Dallas : Mary Crowley Cancer Research Centers
Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Dallas : Mary Crowley Cancer Research Centers
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Dallas : Mary Crowley Cancer Research Centers
Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Dallas : Mary Crowley Cancer Research Centers
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Dallas : Mary Crowley Cancer Research Centers (MCCRC)
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Dallas : Mary Crowley Medical Research Center
Safety Study of Infusion of SGT-53 to Treat Solid Tumors
Dallas : Texas Oncology, PA (North)
Safety Study of PLX108-01 in Patients With Solid Tumors
Denton : Texas Oncology - Denton South
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
El Paso : Texas Oncology - El Paso Cancer Treatment Center Gateway
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
El Paso : Texas Oncology - El Paso Cancer Treatment Center Grandview
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : Texas Oncology - Fort Worth 12th Avenue
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : Texas Oncology - Southwest Fort Worth
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Fort Worth : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ft. Sam Houston : Brooke Army Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Galveston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Grapevine : Texas Oncology
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Houston : UT MD Anderson Cancer Center
4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Houston : UT MD Anderson Cancer Center Updated
5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Houston : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Houston : MD Anderson Cancer Center
A Dose Escalation Study of an Antibody in Patients With Advanced Cancers
Houston : M.D. Anderson Cancer Institute
A Dose Escalation Study of an Antibody in Patients With Advanced Cancers
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Patients With Advanced Cancer
Houston : Research Site
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Houston : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Houston : University of Texas, M.D. Anderson Cancer Center
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
Houston : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Houston : The University Of Texas Md Anderson Cancer Center
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Houston : Call for Information (Investigational Site 0012)
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Houston : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Houston : The University of Texas M. D. Anderson Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Houston :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Houston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Houston : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Houston : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Houston : Site Reference ID/Investigator# 26524
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Houston : 1200.89.10004 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Houston : UT MD Anderson Cancer Center
Bendamustine and Bevacizumab for Advanced Cancers
Houston : UT MD Anderson Cancer Center
Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Houston : The University of Texas MD Anderson Cancer Center
Combination Trial MSC1936369B With Temsirolimus
Houston : UT MD Anderson Cancer Center
Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy
Houston : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Houston : U T M D Anderson Cancer Center
Dose-escalation Study of Oral CX-4945
Houston : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Houston : M.D. Anderson Cancer Center
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
Houston : M.D. Anderson Cancer Center
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced Solid Tumors
Houston : UT MD Anderson Cancer Center
Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Houston : MD Anderson Cancer Center
MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Houston : Gastroenterology Associates, PA
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Houston : Advanced Clinical Research of Houston
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Houston : Research Site
Panitumumab Pediatric Study
Houston : UT MD Anderson Cancer Center
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Houston : UT MD Anderson Cancer Center
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Houston :
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Houston : MD Anderson Cancer Center
Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Houston :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Houston : UT MD Anderson Cancer Center
Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Houston : University of Texas M.D. Anderson Cancer Center
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Houston : University of Texas MD Anderson Cancer Center
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Houston : Call for Information (Investigational Site 0002)
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Houston : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Houston : MD Anderson Cancer Center
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Houston : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Houston : Oncology Consultants
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Houston : MD Anderson Cancer Center
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
Houston : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Houston : MD Anderson Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Houston : University of Texas - MD Anderson Cancer Center
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Houston : UT MD Anderson Cancer Center
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Houston : UT MD Anderson Cancer Center
Tolvaptan in Hyponatremic Cancer Patients
Houston : University of Texas - MD Anderson Cancer Center
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Killeen : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Kyle : Texas Oncology - Kyle
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lewisville : Texas Oncology - Lewisville
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lubbock : 1200.75.10014 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lubbock : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
McAllen : Urology Associates of South Texas
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Mcallen : Urology Associates of South Texas Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Midland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Paris : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Round Rock : Texas Oncology - Round Rock
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Round Rock : Texas Oncology - Seton-Williamson
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Round Rock : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Antonio : Call for Information (Investigational Site 0001)
A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)
San Antonio : Investigational Site Number 840006
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
San Antonio : University of Texas Health Science Center at San Antonio
A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
San Antonio : South Texas Accelerated Research Therapeutics (START)
A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
San Antonio : South Texas Accelerated Research Therapeutics, LLC
A Study of DS-2248, in Subjects With Advanced Solid Tumors
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 in Patients With Advanced Cancer
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
San Antonio : Urology San Antonio Research, PA
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
San Antonio :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
San Antonio : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Antonio : Methodist Hospital - Texas Transplant Institute
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
San Antonio : InVisions Consultants, LLC- c/o Institute for Women's Health
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio : InVisions Consultants, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
San Antonio : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
San Antonio : South Texas Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
San Antonio : University of Texas, Health Science Center,Cancer Therapy and Research Center
Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics, LLC
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
San Antonio : Investigational Site Number 840001
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
San Antonio : Cancer Therapy & Research Center at UTHSCSA
Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
San Antonio : Medical Therapy and Research
NP2 Enkephalin For Treatment of Intractable Cancer Pain
San Antonio : START
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
San Antonio :
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics (START)
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
San Antonio : Investigational Site Number 840006 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
San Antonio : South Texas Accelerated Research Therapeutics (START)
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
San Antonio : South Texas Accelerated Research Therapeutics
Safety Study of AB0024 in Patients With Advanced Solid Tumors
San Antonio : START (South Texas Accelerated Research Therapeutics)
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
San Antonio : Urology San Antonio Research
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
San Antonio :
Sorafenib Long Term Extension Program (STEP)
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
San Antonio : Cancer Therapy and Research Center
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
San Antonio : University of Texas Health Science Center San Antonio
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
San Antonio : The START Center
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
San Antonio : Cancer Therapy & Research Center at the UT Health Science Center
Study of MLN4924 in Adult Patients With Nonhematologic Malignancies
San Antonio : Institute for Drug Development
Study of MLN4924 in Adult Patients With Nonhematologic Malignancies
San Antonio : South Texas Accelerated Research Therapeutics (START)
Study of NMS-1116354 in Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics (START)
Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies
San Antonio : START- South Texas Accelerated Research Therapeutics, LLC
Study of PM060184 in Patients With Advanced Solid Tumors
San Marcos : Texas Oncology - San Marcos
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sherman : Texas Oncology - Sherman
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sugar Land : Texas Oncology - Sugar Land
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Temple : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
Tyler : Tyler Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Tyler : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Tyler : Digestive Health Specialists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Tyler : Digestive Health Specialists of Tyler
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Tyler : Tyler Cancer Center, Texas Oncology
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Webster : Texas Oncology - Deke Slayton Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Utah
Logan : Advanced Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Murray : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Ogden : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Ogden : Advanced Research Institute Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Ogden : Advanced Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
View More »
Salt Lake City : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Salt Lake City : Huntsman Cancer Center, University of Utah
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Salt Lake City :
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Salt Lake City : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Salt Lake City : Wasatch Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Salt Lake City : Novartis Investigative Site
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Salt Lake City : Novartis Investigative Site Updated
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Salt Lake City : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Salt Lake City : Investigational Site Number 840002
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Salt Lake City : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Salt Lake City : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Salt Lake City : Huntsman Cancer Institute
MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Salt Lake City : University of Utah
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Salt Lake City : Salt Lake Research, PLLC
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Salt Lake City : Huntsman Cancer Center
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Salt Lake City : University of Utah
Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Salt Lake City : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Salt Lake City : Huntsman Cancer Institute
Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies
Salt Lake City : Novartis Investigative Site
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
Sandy : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Sandy : Advanced Research Institute Updated
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Sandy : Advanced Research Institute
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Vermont
Burlington : 1200.75.10011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Virginia
Annandale : North Virigina Pelvic Surgery Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Charlottesville : University of Virginia Health System Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Charlottesville : Charlottesville Medical Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Charlottesville : University of Virginia
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Chesapeake : Chesapeake Regional Medical Center
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
View More »
Chesapeake : Gastroenterology Associates of Tidewater
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Hampton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
McLean : National Center for Plastic Surgery
Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study
Norfolk : Urology of Virginia / SMG
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Norfolk : Urology of Virginia, Sentara Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Norfolk : Digestive and Liver Disease Specialists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Norfolk : Clinical Research Associates of Tidewater
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Norfolk : Gastroenterology Associates of Tidewater
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Norfolk : Digestive and Liver Disease Specialists
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Norfolk :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Richmond : McGuire Veterans Affairs Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Richmond : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Richmond : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Roanoke : Carilion Clinic Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Roanoke : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Virginia Beach : Urology of Virginia
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Virginia Beach : Gastroenterology Associates of Tidewater
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Washington
Bellevue : Northwest Gastroenterology Associates
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Burien : Seattle Urology Research Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Burien : Seattle Urology Research Center Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Renton : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Seattle : Seattle Cancer Care Alliance
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
View More »
Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Seattle : Site Reference ID/Investigator# 23285 Updated
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Seattle : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Seattle :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Seattle : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Seattle : Swedish Cancer Institute
Breath Test for Early Detection of Lung Cancer
Seattle : Virginia Mason Medical Center
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Seattle : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Seattle : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Seattle : Fred Hutchinson Cancer Research Center
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Seattle : Seattle Cancer Care Alliance/Fred Hutchinson Cancer Res Ctr/Univ. of Washington Med Ctr
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Seattle : Virginia Mason Medical Center
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Seattle : Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Spokane : Medical Oncology Associates, PS
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Spokane : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Spokane : Medical Oncology Associates
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Spokane : Evergreen Hematology & Oncology
Safety Study of PLX108-01 in Patients With Solid Tumors
Spokane Valley : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tacoma :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Tacoma : Site Reference ID/Investigator# 43422
A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
Tacoma : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tacoma : Comprehensive Clinical Development NW, Inc.
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
Tacoma : Site Reference ID/Investigator# 53008
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Dose-Escalation Study in Participants With Advanced Cancer
Vancouver : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Vancouver : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Wenatchee : Wenatchee Valley Medical Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Wenatchee : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Wenatchee : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Wenatchee : 1200.75.10024 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
West Virginia
Beckley : Raleigh Regional Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Elkins : Davis Memorial Cancer Care Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Morgantown : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Morgantown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Morgantown : Mohammed Ashraf MD
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Wheeling : The Schiffler Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Wisconsin
Green Bay : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Green Bay : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
La Crosse : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
La Crosse : Gundersen Lutheran
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Madison :
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View More »
Madison : University of Wisconsin Comprehensive Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Madison : University of Wisconsin Madison, Carbone Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer
Madison : University Of Wisconsin
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Madison : University of Wisconsin Paul P Carbone Comprehensive Cancer Center
Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors
Madison : Kenneth DeSantes., MD
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Madison : GI Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Madison : University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies
Madison : University of Wisconsin Carbone Cancer Center
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Madison : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Marshfield : Marshfield Clinic
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Milwaukee : Medical College of Wisconsin, Inc. Updated
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Milwaukee : Updated
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Milwaukee : Wisconsin Center for Advanced Research
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Milwaukee : Children's Hospital of Wisconsin
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Waukesha : Waukesha Memorial Hospital (ProHealth Care)
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Wauwatosa : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
West Allis : Aurora West Allis Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Weston : Marshfield Clinic Weston Center
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Argentina
Buenos Aires : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Buenos Aires : 1200.75.54005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Capital Federal : 1200.75.54001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Cordoba : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
View More »
La Plata : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Mendoza : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Quilmes : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Quilmes : 1200.75.54003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rosario : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Rosario : 1200.75.54004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rosario : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Santa Fe : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Vicente Lopez : Htal Vicente Lopez
Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients
Australia
Adelaide : 1200.131.06152 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Adelaide : The Queen Elizabeth Hospital
Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer
Adelaide : Royal Adelaide Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Adelaide SA : RAH Cancer Centre, Royal Adelaide Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Bentleigh East : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
View More »
Bentleigh East : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Box Hill : Investigational Site Number 036004
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Box Hill : 1200.75.61005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Box Hill : Investigational Site Number 036001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Campbelltown : Investigational Site Number 036020
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Camperdown : Investigational Site Number 036001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Camperdown : Investigational Site Number 036002
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Clayton : Investigational Site Number 036001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Douglas : Investigational Site Number 036011
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
East Bentleigh : 1200.89.61002 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
East Melbourne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2874455 in Patients With Advanced Cancer
East Melbourne : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
East Melbourne : Novartis Investigative Site
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Fitzroy : 1200.75.61001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Footscray : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Heidelberg : Site Reference ID/Investigator# 52203
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types
Heidelberg : Site Reference ID/Investigator# 60619
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Heidelberg : 1200.123.6105 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Heidelberg (Melbourne) : Ludwig Institute Tumor Targeting Program, Austin Health
An Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Hobart : 1200.131.06153 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Kingswood : Investigational Site Number 036002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kogarah : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kogarah : Investigational Site Number 036004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kurralta Park : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Kurralta Park : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Melbourne : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Melbourne : Peter MacCallum Cancen Center
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Melbourne : The Alfred Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Nambour : Investigational Site Number 036019
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Nedlands : 1200.123.6106 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Nedlands : Linear Clinical Research Ltd
Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours
North Adelaide : Investigational Site Number 036023
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Parkville : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Parkville : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Parkville : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Parkville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2874455 in Patients With Advanced Cancer
Parkville : Investigational Site Number 036008
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Parkville : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Parkville : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Perth : Investigational Site Number 036005
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Perth : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Perth : Royal Perth Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Perth : GSK Investigational Site
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Port Macquarie : Investigational Site Number 036003
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Port Macquarie : 1200.75.61002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Prahran : The Alfred Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Randwick : Investigational Site Number 036025
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Randwick : Research Site Updated
Phase I Comparative Bioavailability Study
Randwick : Investigational Site Number 036003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Randwick :
Sorafenib Long Term Extension Program (STEP)
Randwick : Investigational Site Number 036003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Ringwood East : 1200.75.61004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
South Brisbane : 1200.89.61001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
South Brisbane : Investigational Site Number 036022
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
South Brisbane : Investigational Site Number 036009
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
South Brisbane : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
South Brisbane : 1200.123.6103 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
South Brisbane : Mater Adult Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Southport : Investigational Site Number 036017
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
St Leonards : Investigational Site Number 036012
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Sydney : Investigational Site Number 036013
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Sydney : Investigational Site Number 036010
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Sydney : The Mater Hospital
Use of Hair to Diagnose Breast Cancer
Tweed Heads : Investigational Site Number 036016
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Victoria : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Wahroonga : 1200.75.61003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wendouree : Investigational Site Number 036024
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Westmead : Investigational Site Number 036007
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Westmead : Westmead Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Wodonga : Investigational Site Number 036015
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Wodonga : Border Medical Oncology
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Wodonga : Investigational Site Number 036002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Woodville South : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Woodville South : The Queen Elizabeth Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Wooloongabba : 1200.131.06151 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Austria
Graz : 1200.75.43003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Graz : Graz Medical University
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Innsbruck : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leoben : 1200.43.04303 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Linz : 1200.75.43002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Salzburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salzburg : 1200.43.04305 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Salzburg : 1200.131.04355 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Steyr : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vienna : Merck Sharp & Dohme Gmbh
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Vienna : 1200.75.43005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wien : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wien : 1200.75.43001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wien : 1200.75.43004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wien : 1200.43.04301 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Wien : 1200.131.04351 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Belgium
Antwerp : AZ Stuivenberg
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Antwerp : ZNA Middelheim Oncologie
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Antwerpen : 1200.75.32004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Antwerpen : Investigational Site Number 056003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Brasschaat : 1200.75.32008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Brussel : University Ziekenhuis
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Brussels :
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Brussels : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Brussels : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Brussels : Jules Bordet Institute
Trial of MSC1936369B in Subjects With Solid Tumours
Bruxelles : Merck Sharp & Dohme B.V.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Bruxelles : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bruxelles :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bruxelles : 1200.75.32001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bruxelles : 1200.43.03202 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Bruxelles : 1287.1.3201 Boehringer Ingelheim Investigational Site
Monotherapy Dose Finding With BI 847325 in Solid Tumours
Bruxelles : Investigational Site Number 056002 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Bruxelles : Investigational Site Number 056002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bruxelles : Hôpital Erasme
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Hôpital Saint Pierre
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : CHU Brugmann
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Institut Jules Bordet
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
Bruxelles - Brussel :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Bruxelles - Brussel :
Sorafenib Long Term Extension Program (STEP)
Charleroi : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleroi : 1200.131.03256 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Charleroi :
Sorafenib Long Term Extension Program (STEP)
Edegem :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Edegem :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Edegem : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Edegem : 1200.75.32005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Edegem : 1200.43.03203 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Edegem : 1200.131.03251 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Edegem : Investigational Site Number 3219
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Gent : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gent : 1200.43.03204 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Gent : Investigational Site Number 056001 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Ghent : Ghent University Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Hasselt : 1200.131.03255 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Ixelles : HIS Ixelles
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Jette : AZ VUB
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Jette : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Kortrijk : 1200.131.03253 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Kortrijk : Investigational Site Number 3212
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Leuven : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Leuven : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Leuven : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Leuven : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leuven : 1200.43.03201 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Leuven : 1287.1.3202 Boehringer Ingelheim Investigational Site
Monotherapy Dose Finding With BI 847325 in Solid Tumours
Leuven : Research Site Updated
Phase I Comparative Bioavailability Study
Leuven : Investigational Site Number 056001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Leuven : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Leuven : University Hospitals Leuven
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Leuven : Investigational Site Number 3211
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Libramont : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Liege : CHR Citadelle
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Liege : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Liège : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Liège : 1200.75.32003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Liège : 1200.131.03254 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Liège : 1200.131.03252 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Namur : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Namur : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Namur : Investigational Site Number 3213
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oostende : 1200.75.32007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Turnhout : AZ Turnhout Dienst Urologie
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Wilrijk :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Wilrijk : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Wilrijk :
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Wilrijk : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Wilrijk : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Wilrijk : Investigational Site Number 3218
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Yvoir : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Yvoir : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Bosnia and Herzegovina
Banja Luka : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Mostar : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Sarajevo : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Sarajevo : Klinicki Centar Univerziteta Sarajevo - Klinika za gastroenterohepatologiju
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Tuzla : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Brazil
Belo Horizonte : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Cachoeiro de Itapemirim : 1200.75.55003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Campinas : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Curitba : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Curitiba : 1200.75.55010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Goiania : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Goiânia/Go : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Ijui : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Ijuí : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
ItajaÃ- : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto Alegre : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Porto Alegre : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto Alegre : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Porto Alegre : 1200.75.55005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Porto Alegre : 1200.75.55002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Porto Alegre : 1200.75.55008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Porto Alegre : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Ribeirão Preto : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Ribeirão Preto/Sp : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Rio de Janeiro : 1200.75.55004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rio de Janeiro : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
São Paulo : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salvador : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santo Andre : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Sao Jose Do Rio Preto : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Sao Paulo :
Sorafenib Long Term Extension Program (STEP)
Sao Paulo : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
São Paulo : 1200.75.55007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Vila Belmiro : 1200.75.55001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bulgaria
Plovdiv : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Shoumen : Site 1
Tapentadol in Chronic Malignant Tumour Related
Sofia : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Sofia : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Sofia : Merck Sharp & Dohme IDEA Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Sofia : Investigational Site Number 100001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Stara Zagora : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Varna : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Varna : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Canada
Abbotsford : Exdeo Clinical Research Inc.
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Abbotsford : Investigational Site Number 124015
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Brampton : Investigational Site Number 124018
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Brantford : Brandord Urology Research
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Burnaby : Investigational Site Number 124014
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
View More »
Calgary : Tom Baker Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Calgary : University of Calgary
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Calgary : University of Calgary
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Calgary :
Sorafenib Long Term Extension Program (STEP)
Edmonton : Cross Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Edmonton : Updated
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
Edmonton : Local Institution
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Edmonton : 1200.92.1001 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours
Edmonton : Cross Cancer Institute
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
Edmonton : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Edmonton : 1200.67.11001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Edmonton : 1200.123.1005 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Edmonton : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Edmonton : University of Alberta Cross Cancer Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Edmonton : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Edmonton :
Sorafenib Long Term Extension Program (STEP)
Granby : Theradev Clinical Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Greenfield Park : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Greenfield Park : 1200.67.11003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Greenfield Park : Investigational Site Number 124011
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Halifax : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Halifax : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Halifax : Queen Elizabeth II Health Sciences Centre
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Hamilton : Juravinski Cancer Centre
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Hamilton : 1200.92.1002 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours
Hamilton : Juravinski Cancer Centre
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors
Hamilton : Investigational Site Number 124010
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Hamilton : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Hamilton : Juravinski Hospital & Cancer Centre
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Kelowna : Southern Interior Medical Research, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Kingston : Centre for Applied Urological Research, Queen's University
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Kirkland : Merck Frosst Canada Ltd.
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Kirkland : Merck Frosst Canada Ltd.
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
Kirkland : Merck Frosst Canada Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Kitchener : 1200.75.11004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Laval : Investigational Site Number 124009
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
London : London Health Sciences Centre Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Moncton : Investigational Site Number 124007
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Moncton : 1200.75.11002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Montreal : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Montreal :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Montreal : CHUM-Hospital Notre Dame
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Montreal : McGill University
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
Montreal : MUHC- Montreal General Hospital
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Montreal : The Urology Specialists
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Montreal : Investigational Site Number 124001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Montreal : 1200.75.11001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Montreal : 1200.67.11002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Montreal : 1200.131.00153 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Montreal : 1200.131.00154 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Montreal : 1200.123.1001 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Montreal : 1200.123.1007 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Montreal : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Montreal :
Sorafenib Long Term Extension Program (STEP)
Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
Montreal : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Montreal : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Montreal : Investigational Site Number 124002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Montreal : Hopital Maisonneuve-Rosemont
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Montréal : Investigational Site Number 124001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Newmarket : Mor Urology Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
North Bay : Office of Dr. Bernard Goldfarb Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Oakville : The Fe/Male Health Centres Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Oshawa : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Oshawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Oshawa : 1200.123.1006 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Oshawa : Investigational Site Number 124013
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Ottawa :
A Study of RO5458640 in Patients With Advanced Solid Tumors
Ottawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ottawa : Investigational Site Number 124012
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Ottawa : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Ottawa : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Pointe-Claire : Ultra-Med, Inc. Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Province of British Columbia : Can-Med Clinical Research Inc.
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Quebec : Investigational Site Number 124010
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Quebec : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Quebec City : Centre Hospitalier Universitaire de Quebec- L'Hotel-Dieu de Quebec Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Saint John : Investigational Site Number 124002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Saskatoon : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Scarborough : Urology and Male Infertility Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Sherbrooke : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Sherbrooke : Investigational Site Number 124004
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Sherbrooke : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Sudbury : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Sudbury : Investigational Site Number 124008
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Surrey : 1200.123.1004 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Surrey : Investigational Site Number 124007
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Toronto : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Toronto :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Toronto : Princess Margaret Hospital
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Toronto : Princess Margaret Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Toronto : 1300.2.1001 Boehringer Ingelheim Investigational Site
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
Toronto : Local Institution
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Toronto :
A Study of RO5458640 in Patients With Advanced Solid Tumors
Toronto : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Toronto : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Toronto : Local Institution
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Toronto : Local Institution
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Toronto : Investigational Site Number 124003
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Toronto : Princess Margaret Hospital - University Health Network Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Toronto : Sunnybrook Health Sciences Centre Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Toronto : UHN Princess Margaret Hospital
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
Toronto : Sunnybrook Health Sciences Centre
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Toronto : Investigational Site
Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma
Toronto : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Toronto : 1200.75.11003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Toronto : 1200.67.11004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Toronto : Princess Margaret Hospital
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Toronto : Investigational Site Number 124003
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Toronto : Investigational Site Number 124002
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Toronto : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Toronto :
Sorafenib Long Term Extension Program (STEP)
Toronto : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Toronto : Investigational Site Number 124003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Truro : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Vancouver : British Columbia Cancer Agency
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Vancouver : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Vancouver : Updated
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
Vancouver : Local Institution
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Vancouver : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Vancouver : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vancouver : 1200.131.00152 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Vancouver : 1200.123.1002 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Vancouver : Investigational Site Number 124001
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Vancouver : University of British Columbia
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Vancouver : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Vancouver : British Columbia Cancer Agency, Vancouver Center
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Vancouver : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Vancouver : Vancouver General Hospital
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Victoria : Pacific Urologic Research Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Victoria : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Windsor : 1200.131.00151 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Winnipeg : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Winnipeg : CancerCare Manitoba
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Chile
Paraiso : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Providencia, Santiago : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Santiago : Merck Sharp & Dohme (I.A.) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Santiago : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Temuco : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
View More »
Temuco : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Temuco : 1200.75.56001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
China
Beijing : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
Beijing : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Beijing : Pfizer Investigational Site
Aromasin® Non-Interventional Study Of Early Invasive Breast Cancer Patients In China
Beijing : Updated
Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy
View More »
Beijing : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Beijing : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Beijing : 1200.75.86001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Beijing : 1200.75.86002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Beijing : 1200.75.86003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Beijing : 1200.75.86004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Beijing : 1200.75.86005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Beijing : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Bejing : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Changchun : 1200.75.86008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Chendu : Department of oral and maxillofacial surgery, Huaxi university of medical science
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Chengdu : 1200.75.86021 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Chengdu : West China Hospital, Sichuan University
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
Chongqing : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Dalian : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Fuzhou : 1200.75.86019 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fuzhou : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Guangzhou : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Guangzhou : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Guangzhou : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Guangzhou : Sun Yat-Sen University Cancer Center
Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors
Guangzhou : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Guangzhou : 1200.75.86016 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Guangzhou : 1200.75.86018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Guangzhou : 1200.75.86017 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Guangzhou : Novartis Investigative Site
Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Guangzhou : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
GuangZhou : Cancer Center of Sun-Yat Sen University (CCSYSU)
Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
Haerbin : 1200.75.86022 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hangzhou : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Hangzhou : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Hangzhou : 1200.75.86012 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hangzhou : 1200.75.86013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hangzhou : GCP center,First Affiliated Hospital of Zhejiang University
Safety Study of FLP Injection to Treat Tumor Patients
Hong Kong : Queen Elizabeth Hospital
Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Hong Kong : Department of Urology, Prince of Wales Hospital
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Jiangsu : Jiangsu Province Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Jinan : 1200.75.86015 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Nanjing : Jiangsu Provincial Centre for Disease Control and Prevention
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Nanjing : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Nanjing : 1200.75.86011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Shanghai : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Shanghai : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Shanghai : 1200.75.86010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Shanghai : 1200.75.86009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Shanghai : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Shanghai : Sanofi-Aventis Administrative Office
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial
Tianjin : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Tianjin : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Tianjin : 1200.75.86006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Tianjin : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Wuhan : GSK Investigational Site
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Wuhan : 1200.75.86020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wuhan : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Xi'an : Dept. Resp. Diseases, Xijing Hospital
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Colombia
Bogota : Frosst Laboratories Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Floridablanca-Santander : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Montería : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Croatia
Pula : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Split : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Zagreb : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Zagreb : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Zagreb : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Czech Republic
Benesov :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Benešov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Brno : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Brno : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Brno : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
View More »
Ceske Budejovice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Ceske Budejovice : 1200.75.42004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
České Budějovice : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Hradec Kralove : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hradec Kralove :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Jicin : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Jihlava : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Most :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nemocnicni :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nemocnicni : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Olomouc : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Olomouc : 1200.75.42003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Olomouc : 1200.43.04202 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Olomouc : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Olomouc : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Ostrava-Poruba :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Plesi :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Plzen :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Prague : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Prague 2 : 1200.75.42001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Prague 2 : 1200.43.04203 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Prague 8 : 1200.43.04201 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Praha : Merck Sharp & Dohme IDEA Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Praha 2 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 2 : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Praha 4 : 1200.75.42002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Praha 5 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 8 : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Sokolov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Sumperk : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Teplice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Teplice : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Denmark
Aalborg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Aalborg : Dept. of Breast Surgery; Aalborg Sygehus
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Aarhus : Department of Oncology
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Århus : Dept. of Oncology; Århus Sygehus
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Århus : Dept. of Surgery; Århus Sygehus
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
View More »
Århus N : Childrens Department of Oncology A4, Aarhus Universityhospital, Skejby
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Copenhagen : Rigshospitalet, Finsen Centret
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Copenhagen : Dept. of Oncology; Rigshospitalet
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Copenhagen : Dept. of Breast Surgery; Rigshospitalet
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Esbjerg : Dept. of Oncology; Sydvestjysk Sygehus Esbjerg
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Esbjerg : Dept. of Surgery; Sydvestjysk Sygehus Esbjerg
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Herlev : Herlev Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Herlev : Dept. of Oncology; Herlev Hospital
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Herlev : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Herlev : Dept. of Breast Surgery; Herlev Hospital
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Herning : Dept. of Oncology; Regionshospitalet Herning
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Hillerød : Dept. of Oncology; Nordsjællands Hospital Hillerød
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Holbaek : Pharmacosmos
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
København Ø : 1200.43.04501 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Næstved : Næstved Sygehus
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Næstved : Dept. of Oncology; Sygehus Syd Næstved
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Odense : Department of Oncology, Odense University Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Odense : Dept. of Oncology; Odense University Hospital
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Odense : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Odense : Dept. of Oncology; Odense University Hospital
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Ringsted : Depart. of Breast Surgery, Ringsted Sygehus
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Rønne : Dept. of internal medicine; Bornholms Hospital
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Roskilde : Dept. of Oncology; Sygehus Øst Roskilde
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Vejle : Dept. of Oncology; Vejle Sygehus
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Vejle : Dept. of Breast Surgery; Vejle Sygehus
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Viborg : Dept. of Oncology; Regionshospitalet Viborg
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Viborg : Dept. of Breast Surgery; Regionshospitalet Viborg
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
Ecuador
Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Estonia
Tallinn : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tallinn : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Finland
Helsinki : Docrates Hospital
CGTG-102 for Therapy of Advanced Cancers
Helsinki : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Helsinki : 1200.67.35801 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Helsinki : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
HUS : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Jyvaskyla : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Kotka : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Kouvola : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Kuopio : Kuopio University Hospital
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Kuopio : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Kuopio : 1200.67.35804 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lahti : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lahti : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Lappeenranta : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Mikkeli : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Oulu : Oulu Univerity Hospital
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Oulu : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Oulu : 1200.131.35853 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Pori : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Rauma : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Seinajoki : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Tampere : University of Tampere
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Tampere : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tampere : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Tampere : 1200.67.35802 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Tampere : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Turku : Department of Oncology and Radiotherapy, turku University Hospital
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Turku : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Turku : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Turku : 1200.67.35803 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Turku : 1200.131.35851 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Turku : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Vaasa : Vaasa Distric Hospital
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Vaasa : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
France
Amiens Cedex 1 : 1200.75.33020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Angers : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Angers : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Angers Cedex 9 : 1200.75.33011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Annecy : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
View More »
Avignon : 1200.43.03304 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Bayonne : 1200.123.3307 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Besançon Cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Besançon Cedex : 1200.75.33007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Besançon Cedex : 1200.131.03358 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Bordeaux :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Bordeaux : Service de chirurgie digestive - hôpital Saint André - 1 rue Jean Burguet
Local Excision in Downstaged Rectal Cancer
Bordeaux : Service de Chirurgie Oncologique - Institut Bergonié - 229, cours de l'Argonne
Local Excision in Downstaged Rectal Cancer
Bordeaux : Service de Radiothérapie - Clinique Tivoli - 220 rue Mandron
Local Excision in Downstaged Rectal Cancer
Bordeaux : 1200.75.33015 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bordeaux : 1200.75.33009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bordeaux : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Bordeaux :
Sorafenib Long Term Extension Program (STEP)
Bordeaux : Institute Bergonié
Trial of MSC1936369B in Subjects With Solid Tumours
Bordeaux Cedex : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Boulogne Billancourt : Service de Chirurgie Digestive - Hôpital ambroise Paré - 9 avenue Charles de Gaulle
Local Excision in Downstaged Rectal Cancer
Bourgogne : Center Alexis Vaurrin
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Brest cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bretonneau Tours : Centre Hospitalier Régional et Universitaire - Hôpital
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Bron Cedex : Novartis Investigative Site
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Caen : Centre François Baclesse
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
Caen : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Caen Cedex 05 : 1200.123.3305 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Caen Cedex 05 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Castelnau Le Lez : Clinique du Parc CASTELNAU LE LEZ
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients
Clermont Ferrand Cedex 1 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Clermont-Ferrand : Service de Chirurgie Générale et Digestive - Hôtel Dieu - CHU Clermont-Ferrand - Boulevard Léon Malfreyt
Local Excision in Downstaged Rectal Cancer
Clermont-Ferrand : Département de Radiothérapie - Centre Jean Perrin - 58 rue Montalembert
Local Excision in Downstaged Rectal Cancer
Clermont-Ferrand Cedex : 1200.75.33006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Clermont-Ferrand cedex 1 : 1200.67.33010 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Clermont-Ferrand cedex 1 : 1200.43.03306 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Clichy : Service de Chirurgie Générale et Digestive - Hôpital Beaujon - 100 boulevard du Général Leclerc
Local Excision in Downstaged Rectal Cancer
Clichy Cedex : 1200.131.03360 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Colmar : Hôpitaux Civils de Colmar-CH Louis Pasteur
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Colmar : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Dijon : 1200.93.33002 Boehringer Ingelheim Investigational Site
A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel
Dijon : Centre Georges-François Leclerc Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Dijon Cedex : 1200.75.33019 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dijon Cedex : 1200.43.03312 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Ferolles-Attilly : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Grenoble : 1200.75.33017 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
La Roche sur Yon : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
La Roche Sur Yon Cedex 9 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
La Tronche : Service de Chirurgie Digestive - Hôpital A. Michallon - CHU de Grenoble - Boulevard de la Chantourne
Local Excision in Downstaged Rectal Cancer
Le Havre : 1200.131.03353 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Le Mans : 1200.75.33014 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lille : Department of Obstetrics and Gyneacology, Lille University Hospital
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Lille : Département de Chirurgie Oncologique - Centre Oscar Lambret - 3 rue Combemale
Local Excision in Downstaged Rectal Cancer
Lille : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Lille Cedex : 1200.75.33005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lille Cedex : 1200.67.33008 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lille Cedex : 1200.43.03303 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Lille Cedex : 1200.131.03351 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Lille Cedex : Investigational Site Number 250002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Limoges Cedex : 1200.75.33010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Limoges Cedex : 1200.123.3308 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Limoges Cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Lyon : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Lyon :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Lyon :
A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Lyon : Département de Chirurgie Oncologique - Centre Léon Bérard - 28 rue Laennec
Local Excision in Downstaged Rectal Cancer
Lyon : Service de Chirurgie Générale - Hôpitaux Civils de Lyon
Local Excision in Downstaged Rectal Cancer
Lyon : Centre Hospitalier Lyon Sud
Phase I Study of mPEG-R-Crisantaspase Given IV
Lyon : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Lyon Cedex : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Lyon Cedex : 1200.43.03301 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Lyon Cedex 08 : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Lyon Cedex 08 : 1200.67.33001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lyon Cedex 08 : 1200.123.3301 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Lyon Cedex 3 : Hopital Edouard Herriot
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Marseille : Institut Paoli Calmette
Local Excision in Downstaged Rectal Cancer
Marseille : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Marseille : Investigational Site Number 250003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Marseille Cedex 09 : 1200.67.33004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Marseille Cedex 20 : Updated
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Marseille Cedex 5 : 1200.131.03362 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Marseille Cedex 5 : Novartis Investigative Site
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Montbéliard Cedex : 1200.131.03361 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Montellier cedex 5 : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Montpellier : Département de Chirurgie Oncologique - CRLC Val d'Aurelle
Local Excision in Downstaged Rectal Cancer
Montpellier cedex 5 : 1200.43.03302 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Montpellier Cedex 5 : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Nantes : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Nantes : 1200.75.33013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Nantes : Hospital Hotel Dieu, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Nantes Cedex 01 : Investigational Site Number 250005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Nantes Cedex 2 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Nantes-Saint Herblain : Centre René Gauducheau
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
Nice : Centre Antoine Lacassagne
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Nice : Service de Chirurgie Générale - Hôpital Archet II
Local Excision in Downstaged Rectal Cancer
Nice Cedex 02 : 1200.67.33011 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Nice cedex 2 : 1200.43.03307 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Nice cedex 2 : 1200.131.03359 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Nimes : Investigational Site Number 250004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Paris : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Paris :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Paris : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Paris : Service de Chirurgie Digestive - Hôpital des Diaconnesses - la Croix Saint-Simon - 125 rue d'Avron
Local Excision in Downstaged Rectal Cancer
Paris : Service de Chirurgie Générale et Digestive - Hôpital Saint-Antoine - 184 rue du Faubourg Saint-Antoine
Local Excision in Downstaged Rectal Cancer
Paris : Service d'Oncologie - Radiothérapie - Hôpital Tenon - 4 rue de la Chine
Local Excision in Downstaged Rectal Cancer
Paris : Service de Cancérologie - Radiothérapie - Hôpital Saint-Louis - 1 avenue Claude Vellefeaux
Local Excision in Downstaged Rectal Cancer
Paris : Département Médico-Chirurgical de Pathologie Digestive - Hôpital Lariboisière - 2 rue Ambroise Paré
Local Excision in Downstaged Rectal Cancer
Paris : 1200.75.33012 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Paris : 1200.67.33003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Paris : 1200.123.3303 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Paris : Institut Curie
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
Paris : Hospital Saint Louis, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Paris : Hôpital Beaujon
Trial of MSC1936369B in Subjects With Solid Tumours
Paris : Hopital Saint Louis
Trial of MSC1936369B in Subjects With Solid Tumours
Paris Cedex 05 : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Paris Cedex 05 : 1200.67.33002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Paris Cedex 05 : 1200.43.03314 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Paris Cedex 10 : Investigational Site Number 250001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Pessac Cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Pierre Benite : Service de Radiothérapie - Oncologie - Centre Hospitalier Lyon Sud - Hôpitaux Civils de Lyon - 165 chemin du Grand Revoyet
Local Excision in Downstaged Rectal Cancer
Pierre Benite Cedex : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Pierre Benite Cedex : Investigational Site Number 250002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Pierre Benite Cedex : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Pierre Benite Cedex : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Pierre-Bénite : 1200.131.03355 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Poitiers : 1200.43.03305 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Poitiers Cedex :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Reims : Institute Jean Godinot
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Reims : 1200.75.33001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Reims : 1200.75.33018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rennes : Service de Chirurgie Viscérale - CHU pontchaillou - 2 rue Henri Le Guilloux
Local Excision in Downstaged Rectal Cancer
Rennes : Centre Eugène Marquis
Trial of MSC1936369B in Subjects With Solid Tumours
Rennes Cedex : CHU de Pontchaillou-CIC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Rennes Cedex : 1200.75.33016 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rouen : Centre Hospitalier Universitaire de Rouen
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Rouen : CHU Rouen
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Rouen : Service de Chirurgie Digestive - CHU Charles Nicolle - 1 rue Germont
Local Excision in Downstaged Rectal Cancer
Rouen : Centre Henri Becquerel
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
Rouen Cedex 1 : 1200.43.03316 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Saint Herblain : Service de Chirurgie Oncologique - Centre René Gauducheau - Boulevard Jacques Monod
Local Excision in Downstaged Rectal Cancer
Saint Herblain Cedex : 1200.67.33005 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Saint Herblain Cedex : 1200.43.03309 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Saint Herblain Cedex : 1200.131.03354 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Saint Herblain Cedex : 1200.123.3302 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Sainte Foy les Lyon : Service de Chirurgie Viscérale - Clinique Charcot - 51-52 rue Commandant Charcot
Local Excision in Downstaged Rectal Cancer
Saint-Herblain : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Saint-Herblain cedex : 1200.93.33001 Boehringer Ingelheim Investigational Site
A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel
Saint-Pierre Cedex -La Réunion : 1200.123.3306 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
St Herblain : Centre René Gauducheau
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
St. Etienne Cedex 2 : Clinique Mutualiste
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
St. Herblain Cedex : Medicale Centre René Gauducheau
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Strasbourg : Service de Chirurgie Digestive - Hôpital Hautepierre
Local Excision in Downstaged Rectal Cancer
Strasbourg : Hopitaux Universitaires de Strasbourg, CHU Haute-Pierre
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Strasbourg : University Hospital of Strasbourg
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Strasbourg : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Strasbourg : Novartis Investigative Site
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Strasbourg Cedex : 1200.75.33008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Suresnes Cedex :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Toulouse : Novartis Investigative Sie
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Toulouse :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Toulouse :
A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Toulouse : Investigational Site Number 250003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Toulouse : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toulouse : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Toulouse : Institut Claudius Regaud Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Toulouse : Institute Claudius Regaud
Trial of MSC1936369B in Subjects With Solid Tumours
Toulouse Cedex : 1200.93.33003 Boehringer Ingelheim Investigational Site
A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel
Toulouse Cedex : Investigational Site Number 250001
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
Tours : 1200.131.03356 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Vandoeuvre les Nancy : Service de Chirurgie Digestive et Générale - CHU Brabois - avenue de Bourgogne
Local Excision in Downstaged Rectal Cancer
Vandoeuvre les Nancy cedex : 1200.43.03310 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Villejuif : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Villejuif :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Villejuif : Institute Gustave Roussy
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Villejuif : Institut Gustave-Roussy
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
Villejuif : Institut Gustave Roussy Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Villejuif : Institute Gustave Roussy
Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
Villejuif : Investigational Site Number 250001
Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Villejuif Cedex : Centre Hospitalier Universitaire, Institut Gustave Roussy
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Villejuif Cedex : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Villejuif Cedex : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Villejuif Cedex : Updated
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Villejuif Cedex : Investigational Site Number 250001
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Villejuif Cedex : 1200.43.03317 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Villejuif Cedex : 1200.131.03357 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Villejuif Cedex : Investigational Site Number 250001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Villejuif Cedex : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Villejuif Cedex : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Villejuif Cedex : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Villejuif cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Villejuif, Cedex : Institut Gustave-Roussy (IGR)
Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Georgia
Tbilisi : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Tbilisi : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Germany
Aachen :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Aachen : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Aachen : 1200.75.49004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Aachen : 1200.43.04903 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Aachen : Investigational Site Number 276006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Aalen : Ostalbklinikum
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Bad Klosterlausnitz :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Berlin :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Berlin : AIO-Studien gGmbH
ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction
Berlin : Vivantes Klinikum Neukolln
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Berlin : Universitätsmedizin Charité, Campus Benjamin Franklin, Urologische Klinik and Poliklinik
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Berlin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Berlin : 1200.43.04902 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Berlin : 1200.131.04952 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Berlin : AIO-Studien gGmbH
Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)
Berlin : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Berlin :
Sorafenib Long Term Extension Program (STEP)
Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Bonn : Urologie Bonn Rhein-Sieg
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Bonn : 1200.75.49013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bonn : Department of Gynaecolgy and Obstetrics, University hopsital
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Bonn : Investigational Site Number 276007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Brandenburg an der Havel : 1200.75.49003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Brasov : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Chemnitz : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Deggendorf : 1200.75.49002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dortmund : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Dresden : Universitätsklinikum Dresden
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Dresden : Universitätsklinikum Carl Gustav Carus an der Techischen Universität Dresden, Klinik und Poliklinik für Urologie
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Dresden : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Dresden : 1200.43.04909 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Dresden : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Erlangen : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Erlangen : 1200.75.49009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Erlangen : 1200.67.49002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Essen : Department of Internal Medicine West German Cancer Centre University Hospital Essen
Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas
Essen : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Essen : 1200.75.49021 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Essen : 1200.67.49008 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Essen : 1200.43.04901 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Essen : 1200.131.04954 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Essen : 1200.123.4901 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Essen :
Sorafenib Long Term Extension Program (STEP)
Essen : University hospital, Dept. of gynecology & obstetrics
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Essen : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Esslingen : Klinikum Esslingen
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Foscani : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Frankfurt : Johann-Wolfgang-Goethe-Universität Frankfurt
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Frankfurt : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Frankfurt : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Frankfurt : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Frankfurt : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Frankfurt am Main : Klinikum der JWG Universität Frankfurt
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Frankfurt Am Main : Investigational Site Number 276004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Freiburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Freiburg :
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies
Freiburg : 1200.131.04961 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Freiburg : University Hospital Freiburg Gynecological Clinic
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Freiburg :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Freiburg : Universitätsklinikum Freiburg, Frauenklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Freiburg im Breisgau : Clinic SanaFontis
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Freiburg/Breisgau : 1200.75.49015 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fulda : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Goslar : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Großhansdorf :
Sorafenib Long Term Extension Program (STEP)
Haar : Msd Sharp & Dohme Gmbh
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Halle : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Halle : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Halle (Saale) : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hamburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Hamburg : Urologikum Hamburg, Medizinzentrum Hammoniabad
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Hamburg : 1200.43.04905 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Hamburg : 1200.123.4904 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Hamburg : Department of Gynaecology, University hospital
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Hamburg : University Hospital Hamburg-Eppendorf
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Hamburg :
Sorafenib Long Term Extension Program (STEP)
Hannover : Medizinische Hochschule Hannover
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Hannover : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Hannover : Medizinische Hoochschule Hannover, Allgemein-, Viszeral-und Transplantationscirurgie OE 6220
Influence of Thyroid Hormones on the Woundhealing Process
Hannover : 1200.67.49005 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Hannover : 1200.43.04906 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Hannover : 1200.131.04953 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Hannover : Investigational Site Number 276004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Hannover : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Hannover : Medizinische Hochschule
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Heidelberg : Universitätsklinikum Heidelberg
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Heidelberg : Thoraxklinik
Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System
Heidelberg : 1200.75.49019 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Heidelberg : 1200.67.49006 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Heidelberg : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Heilbronn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Heilbronn :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Herne : Updated
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Hildesheim : 1200.75.49008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Homburg : Universitätsklinikum des Saarlandes
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Iasi : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Jena : Universitätsklinikum Jena
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Jena : Universitätsklinikum Jena
Clinical Study to Evaluate the Safety and Efficacy of recMAGE-A3 + AS-15 in Patients From Which the Bladder is Removed Due to Muscle Invasive Bladder Cancer
Jena :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Jena : 1200.75.49022 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Jena : 1200.43.04908 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Jena : 1200.131.04956 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Jena : Investigational Site Number 276002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Jena : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Jena : Investigational Site Number 276001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Karlsruhe : 1200.75.49016 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Karlsruhe : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Kassel : Hospital Kassel
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Kiel : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Kiel : Universitatsklinikum Schleswig Holstein
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Kiel : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Köln : 1200.75.49006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Köln : 1200.67.49001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Köln : Universiätsklinikum Köln
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Leipzig : 1200.43.04904 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Leipzig : 1200.131.04951 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Leipzig : Universitatsklinikum Leipzig
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Leipzig : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Lunen :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Münster : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Magdeburg : Universitätsklinikum Magdeburg A.ö.R.
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Magdeburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Magdeburg : 1200.75.49014 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Mainz : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mainz : 1200.123.4902 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Mannheim : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mannheim : 1200.75.49018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Mannheim : 1200.43.04907 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Mannheim : 1200.131.04955 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Mannheim : Investigational Site Number 276001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Mannheim : Investigational Site Number 276003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Marburg :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Marburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Memmingen : 1200.75.49023 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Mönchengladbach : 1200.75.49005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
München : Klinikum Rechts der Isar der Technischen Universität
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
München :
Combination With Gemcitabine in Advanced Pancreatic Cancer
München : 1200.75.49007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
München : 1200.67.49007 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Munich : University of Munich - Klinikum Grosshadern
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
Münster : 1200.123.4903 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Nürnberg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Nürtingen : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Offenbach : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Offenburg : St. Josefsklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Oldenburg : 1200.75.49011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Oldenburg : 1200.67.49003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Paderborn : St. Vincenz-Krankenhaus
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Regensburg :
Sorafenib Long Term Extension Program (STEP)
Reutlingen : Praxis Dres. Maier Loffler / Schradin
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Reutlingen : Studienpraxis Urologie
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Rostock : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Rostock : 1200.75.49012 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rostock : Klinikum Südstadt
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Solingen : 1200.75.49020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Stuttgart : Robert-Bosch-Krankenhaus
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Tübingen : Universitätsklinikum Tübinger, Klinik und Poliklinik für Urologie
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Tübingen : 1200.67.49004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Tuebingen : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Ulm : 1200.75.49017 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ulm : Universitätsklinikum, Universitätsfrauenklinik
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Ulm : Investigational Site Number 276002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Villingen-Schwenningen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wiesbaden : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Wolfsburg : Klinikum der Stadt Wolfsburg
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Wuppertal : 1200.75.49024 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Würzburg : Universitätsklinikum Würzburg
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Würzburg : University Hospital Würzburg
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Greece
Athens : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Athens : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Athens : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Chaidari : 1200.131.03054 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Haidari, Athens : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
View More »
Heraklion : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Heraklion, Crete : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Nea Erythrea : Vianex, S.A. / MSD
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Neo Faliro : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Patra : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Perioxi Dragana, Alexandroupolis : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Thessaloniki : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Thessaloniki : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Thessaloniki : 1200.131.03052 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Honduras
Honduras Site Information : Merck Sharp & Dohme (IA) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hong Kong
Causeway Bay : Merck Sharp & Dohme (Asia) Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hong Kong : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Hong Kong : 1200.89.85201 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Hong Kong : Sanofi-Aventis Administrative Office
Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer
Hong Kong : 1200.98.85202 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
View More »
Hong Kong : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Kowloon : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Pokfulam : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Pokfulam : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Sha Tin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Shatin : 1200.98.85201 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Tuen Mun : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Tuen Mun : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tuen Mun : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Hungary
Budapest : Investigational Site Number 348001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Budapest : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Budapest : Orszagos Koranyi TBC es Pulmonologiai Intezet
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Budapest : Országos Korányi TBC és Pulmonológiai Intézet
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Budapest : Semmelweis Egyetem Pulmonológiai Klinika
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
View More »
Budapest : Investigational Site Number 348004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Budapest : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Debrecen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Debrecen : Investigational Site Number 348001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Deszk :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Deszk : Csongrád Megyei Önkormányzat Mellkasi Betegségek Szakkórháza
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Gyor : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Györ : Investigational Site Number 348007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Kaposvár : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Kecskemét : Investigational Site Number 348006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Komarom :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Miskolc :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Miskolc : Investigational Site Number 348003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Nyiregyhaza : Investigator 1
Tapentadol in Chronic Malignant Tumour Related
Nyíregyháza :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nyíregyháza : Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktató Kórháza
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Pécs : Investigational Site Number 348005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Szeged : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Székesfehérvár : Fejér Megyei Szent György Kórház
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Szekszard :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Szolnok : Investigational Site Number 348002
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Szombathely : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Törökbálint : Pest Megyei Tüdőgyógyintézet
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
India
Ahmedabad : 1200.89.91007 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Ahmedabad : Gujarat Cancer Hospital and Research Institute
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Amravati : 1200.75.91010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Amravati : 1200.98.91011 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Andra Pradesh : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
View More »
Aurangabad, Maharashtra : 1200.98.91006 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Bangalore : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Bangalore : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Bangalore : 1200.75.91001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bangalore N/A : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Bengaluru : 1200.75.91016 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bhopa : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Bhopal : Dr. T. P. Sahoo's Clinic
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Chennai : 1200.75.91017 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Gurgaon : 1200.75.91012 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hyderabad : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Hyderabad : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Hyderabad : Bibi general hospital & cancer centre
Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Hyderabad N/A : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Jaipur : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Jaipur : Cancer Clinic
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Jaipur : 1200.98.91003 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Jaipur : SEAROC Cancer Center, S.K.
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Karnataka : 1200.98.91002 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Kerala : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Kolkata : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Kolkata : Apollo Gleneagles Cancer Hospital
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Kolkata : 1200.75.91014 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Kolkata : 1200.75.91009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lucknow : Annapurna Medical and Cancer Relief Society
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Lucknow : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Maharashtra : 1200.75.91007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Maharashtra : 1200.98.91009 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Maharashtra : 1200.98.91010 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Mangalore : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Mumbai : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Mumbai : 1200.89.91003 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Mumbai : Tata Memorial Hospital
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Mumbai : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Mumbai : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Nagpur : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Nagpur : 1200.75.91013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Nagpur : 1200.75.91020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Nagpur : 1200.98.91004 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Nagpur : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Nagpur : Central India Cancer Research Institute
Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Nashik : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Nashik : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Nashik : 1200.75.91006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Nashik : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Nasik : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
New Delhi : 1200.75.91002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New Delhi : 1200.98.91007 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Pune : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Pune : 1200.89.91001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Pune : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Pune : 1200.75.91004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Pune : 1200.98.91001 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Pune : Noble Hospital
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Pune : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Pune : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Secunderabad : Dr. Nikhil's Clinic
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Srinagar : S. K. I. M. S.
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Tamil Nadu Na : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Tamil Naud : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Thiruvananthapuram : 1200.98.91005 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Trivandrum : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Trivandrum : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Uttar Pradesh : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Vellore : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Vellore : 1200.89.91004 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Vellore : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Vijayawada : 1200.75.91018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Visakhapatnam : 1200.75.91005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Indonesia
Bandung : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Jakarta : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Semarang : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Yogyakarta : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Ireland
Cork : Investigational Site Number 372004
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Dubliin 9 : 1200.75.35307 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dublin 4 : 1200.75.35301 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dublin 7 : 1200.75.35303 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dublin 7 : 1200.75.35306 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Dublin 8 : 1200.75.35302 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Israel
Ashkelon : 1200.75.97208 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Haifa : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Haifa : 1200.75.97203 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Haifa : Investigational Site Number 376003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Hod Hasharon : Merck Sharp & Dohme Co. Ltd.
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)
View More »
Jerusalem : Hadassah-Hebrew University Medical Center
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Jerusalem : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Jerusalem : 1200.75.97205 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Jerusalem : Investigational Site Number 376004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Kfar Saba : 1200.75.97210 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Petah-Tikva : Investigational Site Number 376001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Tel Hashomer : 1200.75.97201 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Tel Hashomer : Investigational Site Number 376002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Tel-Aviv : 1200.75.97206 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Italy
Ancona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Ancona : 1230.7.39002 Boehringer Ingelheim Investigational Site
Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors
Ancona : A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy)
Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients
Aosta : 1200.43.03909 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Aviano : Irccs Centro Di Riferimento Oncologico (Cro) - Aviano
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
View More »
Aviano (PN) : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Bergamo : Ospedali Riuniti Di Bergamo
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Bergamo : 1200.75.39004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bergamo : Investigational Site Number 380002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bologna : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Bologna : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Bologna : Investigational Site Number 380007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bologna :
Sorafenib Long Term Extension Program (STEP)
Bologna : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Bologna : Investigational Site Number 380003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Brescia : 1200.131.03954 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Brindisi : 1200.75.39005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Candiolo (to) : 1200.67.39004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Confreria (cn) : 1200.43.03901 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Confreria (cn) : 1200.131.03957 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Ferrara : 1200.75.39008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Firenze : Azienda Ospedaliero UNIVERSITARIA CAREGGI DI FIRENZE
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Firenze : Investigational Site Number 380004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Firenze : Investigational Site Number 380001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Firenze (FI) : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Genova : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Genova : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Genova : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Macerata : ASUR Zona Territoriale 9, Medicina Nucleare Ospedale di Macerata
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Many Locations :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Mendola : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Messina : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Milan : Instituto Europeo di Oncologia
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Milan : Merck Sharp & Dohme (Italia) S.P.A.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Milan : European Institute of Oncology
Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients
Milan : 1200.75.39001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Milano : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Milano : GSK Investigational Site
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Milano : 1230.7.39001 Boehringer Ingelheim Investigational Site
Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors
Milano : Investigational Site Number 380001
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Milano : Investigational Site Number 380002
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Milano : 1200.43.03907 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Milano : 1200.131.03951 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Milano : 1200.131.03955 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Milano : Investigational Site Number 380001 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Milano :
Sorafenib Long Term Extension Program (STEP)
Milano : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Milano : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Milano : European Institute of Oncology
Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
Milano : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Milano : Investigational Site Number 380001
Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Modena : A.O. UNIVERSITARIA POLICLINICO DI MODENA (Italy)
Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients
Modena : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Modena : 1200.67.39001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Monserrato (CA) : 1200.75.39007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Monza : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Napoli : Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Di Napoli
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Napoli : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Napoli : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Napoli : 1200.75.39003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Napoli : 1200.43.03903 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Napoli : 1200.131.03953 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Napoli : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Orbassano :
Sorafenib Long Term Extension Program (STEP)
Orbassano : Investigational Site Number 380004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Padova : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Pavia : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Pavia : Investigational Site Number 380006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Pavia : Investigational Site Number 380001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Pavia :
Sorafenib Long Term Extension Program (STEP)
Perugia :
Sorafenib Long Term Extension Program (STEP)
Pisa :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Pisa :
Sorafenib Long Term Extension Program (STEP)
Prato : 1200.75.39002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Reggio Emilia : Arcispedale Santa Maria Nuova Di Reggio Emilia
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Reggio Emilia : 1200.67.39002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Reggio Emilia :
Sorafenib Long Term Extension Program (STEP)
Rimini : 1200.75.39006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Roma : 1200.131.03959 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Roma : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Roma : Investigational Site Number 380002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Rozzano :
Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations
Rozzano :
Sorafenib Long Term Extension Program (STEP)
Rozzano (mi) : Irccs Istituto Clinico Humanitas
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Rozzano (MI) : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
San Giovanni Rotondo (FG) : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Savona : 1200.43.03902 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Savona : 1200.131.03952 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Torino : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Trento : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Varese : Investigational Site Number 380003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Venezia : 1200.43.03906 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Verona : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Viterbo : 1200.43.03910 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Viterbo : 1200.131.03958 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Japan
Akashi : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Akashi, Hyogo : 1199.117.003 Boehringer Ingelheim Investigational Site
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)
Akashi-Shi : Investigational Site Number 392002
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors
Bunkyo :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Bunkyou-ku : Juntendo University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
View More »
Chiba :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2603618 in Combination With Gemcitabine in Patients With Solid Tumors
Chubu :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Chugoku :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Chuo-Ku : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Chuo-ku : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Chuo-ku, Osaka, Osaka : 1200.84.003 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
Chuo-ku, Tokyo : 1230.15.001 National Cancer Center Hospital,
BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours
Chuo-ku,Tokyo : 1199.117.002 Boehringer Ingelheim Investigational Site
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)
Fukui :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukui-Shi :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukuoka : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Fukuoka : Novartis Investigative Site
A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors
Fukuoka :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Fukuoka City : Kyushu University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Fukuoka N/A :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Fukushima :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukushima N/A :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fukuyama :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Fushimi :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hamamatsu :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hidaka : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Hidaka, Saitama : 1199.117.001 Boehringer Ingelheim Investigational Site
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)
Hidaka-Shi : Investigational Site Number 392001
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors
Hirosaki :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hitachi :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Hokkaido :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Isehara : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Isehara City : Tokai University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Isehara Kanagawa : 1200.43.08109 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Isehara Kanagawa : 1200.131.08159 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Itami :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Iwakuni :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Izumo N/A :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kamogawa :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kansai :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Kansai :
Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors
Kanto :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Kanuma :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kashiwa :
A Phase I Study of E7050 in Subjects With Solid Tumors
Kashiwa : Novartis Investigative Site
A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors
Kashiwa : Pfizer Investigational Site
Asian Phase I Study Of PF-03446962
Kashiwa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kashiwa :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Kashiwa City, Chiba : 1200.43.08103 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Kashiwa City, Chiba : 1200.131.08153 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Kashiwa, Chiba : 1200.84.004 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
Kobe :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kobe : Novartis Investigative Site
A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors
Kobe-city,Hyogo : 1200.43.08107 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Kobe-city,Hyogo : 1200.131.08157 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Kobe-Shi : Investigational Site Number 392002
Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors
Koto-Ku :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Koto-Ku :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Kumagaya :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kumamoto :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kure :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kyoto :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kyoto City : Kyoto University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Kyusyu :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Locations in : For Recruiting
A Study of EMD525797 in Solid Tumor Patients in Japan
Many Locations :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Matsumoto-City :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Matsusaka :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Matsuyama-city, Ehime : 1200.43.08108 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Matsuyama-city, Ehime : 1200.131.08158 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Meguro :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Meguro-ku, Tokyo : 1200.43.08104 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Meguro-ku, Tokyo : 1200.131.08154 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Minato :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Mitaka-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Miyazaki :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Nagasaki City : Nagasaki University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Nagoya : Novartis Investigative Site
A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors
Nagoya :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Nagoya : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Nagoya : Research Site
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies
Nagoya : Research Site
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
Nagoya, Aichi : 1200.84.001 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
Nagoya, Aichi : 1200.43.08106 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Nagoya, Aichi : 1200.131.08156 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Nagoya-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nagoya-shi : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Natori :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Niigata N/A :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ogori :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ohta :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Okayama :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Osaka :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Osaka : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Osaka : Research Site
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients
Osaka : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Osaka : GSK Investigational Site
Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors
Osaka-fu : Kinki University School of Medicine
Study of Tesetaxel in Japanese Patients With Solid Tumors
OTA : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Saga :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Saku :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sakyo-ku, Kyoto, Kyoto : 1200.84.002 Boehringer Ingelheim Investigational Site
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
Sapporo :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sapporo : Research site
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies
Sapporo : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Sapporo : Research Site
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
Sapporo City, Hokkaido : 1200.43.08101 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Sapporo City, Hokkaido : 1200.131.08151 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Sendai :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Shikoku :
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
shimotsuke-shi,Tochigi : 1200.43.08102 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
shimotsuke-shi,Tochigi : 1200.131.08152 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Shinjuku : Tokyo Medical University Hospital
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Sunto :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Sunto :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Sunto-gun : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sunto-gun, Shizuoka : 1200.43.08105 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Sunto-gun, Shizuoka : 1200.131.08155 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Takarazuka :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Takasaki :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Tokyo :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Tokyo : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tokyo : GSK Investigational Site
Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors
Tokyo : MSD K.K.
V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)
Tomakomai :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Toyama :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Toyonaka :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Ube :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yamagata :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yamanashi :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yokohama :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Yokohama :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Yokohama :
Safety, Biodistribution, and Pharmacokinetics Study of BAY88-8223 in Japanese Patients
Yokohama N/A :
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Yokohama-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Yufu : Novartis Investigative Site
A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors
Yufu : Novartis Investigative Site
A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors
Korea, Republic of
Anyang : Hallym University Medical Center
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Anyang : Hyo Jung Kim
Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
Busan :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Busan : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Cheonju-si : 1200.123.8203 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
View More »
Chungcheongbuk-Do :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Daegu :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Daegu :
Sorafenib Long Term Extension Program (STEP)
Dae-Gu :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Deajun :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Gangwon-do : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Goyang : 1200.75.82001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Goyang : 1200.67.82001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Gyeonggi-Do :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Incheon :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Incheon : 1200.123.8204 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Incheon : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Incheon : Gachon University Gil Medical Center
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Jeonnam : Chonnam National University Hwasun Hospital
A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
Jinju-Si :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Kyunggi-do : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Pusan : Inje Pusan paik University hospital
Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer
Seongnam : Investigational Site Number 410002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seongnam : Investigational Site Number 410001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Seoul : Severance Hospital
A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment
Seoul :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Seoul : Research Site
A Study of AZD1480 in Asian Patients With Advanced Solid Malignancies and Asian Patients With Advanced Hepatocellular Carcinoma
Seoul : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2874455 in Patients With Advanced Cancer
Seoul : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Seoul : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Seoul : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Seoul : MSD Korea Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Seoul : Asan Medical Center
A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies
Seoul : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Seoul : Seoul National University Hospital
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
Seoul : Pfizer Investigational Site
Asian Phase I Study Of PF-03446962
Seoul : Seoul National University Hospital
Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors
Seoul : Seoul National University Hospital
Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies (Oratecan-103)
Seoul : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Seoul : Asan Medical Center
Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy
Seoul : 1200.75.82002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Seoul : 1200.75.82005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Seoul : 1200.75.82003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Seoul : 1200.75.82004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Seoul : 1200.75.82006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Seoul : 1200.67.82002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Seoul : 1200.67.82004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Seoul : 1200.67.82003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Seoul : 1200.123.8202 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Seoul : 1200.123.8201 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Seoul : 1200.123.8205 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Seoul : Investigational Site Number 410003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul :
Sorafenib Long Term Extension Program (STEP)
Seoul :
Sorafenib Long Term Extension Program (STEP)
Seoul : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Seoul : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Seoul : Novartis Investigative Site
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Seoul : Investigational Site Number 410002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Investigational Site Number 410003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Investigational Site Number 410004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Department of Surgery, Seoul National University Hospital
The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients
songpa-gu, Seoul : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Suwon :
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Latvia
Daugavpils : 1200.75.37103 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rezekne :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Riga :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Riga : 1200.75.37102 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Riga : 1200.75.37101 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lithuania
Kaunas : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kaunas : 1200.75.37001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Kaunas : Investigational Site Number 440001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Klaipeda :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Klaipeda : Investigational Site Number 440002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Siauliai :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Vilnius : UAB Merck Sharp & Dohme
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Vilnius : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vilnius :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Vilnius : 1200.75.37002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Macedonia, The Former Yugoslav Republic of
Bitola : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Skopje : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Malaysia
Nilai : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Mexico
Chihuahua : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Chihuahua :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Chihuahua : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Colonia Centro : 1200.75.52003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Durango : Investigational Site Number 484002
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
View More »
Durango : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Durango : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Irapuato : Investigational Site Number 484006
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Juchitan : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Merida : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Mexico : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Mexico, D.f. : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Monterrey : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Morelia : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Toluca : Investigational Site Number 484005
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Zapopan : Investigational Site Number 484001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Netherlands
Almelo : Ziekenhuis Groep Twente - locatie Twenteborg Ziekenhuis
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Amsterdam : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Amsterdam : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Amsterdam : Local Institution
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Amsterdam :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
View More »
Amsterdam :
A Study of RO5458640 in Patients With Advanced Solid Tumors
Amsterdam :
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Patients With Metastatic and/or Locally Advanced Malignant HER3-Positive Solid Tumors
Amsterdam : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Amsterdam : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Amsterdam : Nationaal Kanker Instituut (NKI)
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Amsterdam : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Amsterdam : 1200.131.03152 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Amsterdam : Academisch Medisch Centrum
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Amsterdam : Antoni van Leeuwenhoek Ziekenhuis
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Amsterdam : Research Site
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Amsterdam : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Amsterdam : Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Amsterdam : The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors
Arnhem : Ziekenhuis Rijnstate
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Assen : Wilhelmina Ziekenhuis
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Dordrecht : 1200.75.31003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Eindhoven : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eindhoven : Catharina-Ziekenhuis
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Eindhoven : 1200.75.31004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Enschede : 1200.75.31002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Groningen :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Groningen : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Groningen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Groningen : Site Reference ID/Investigator# 44804
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Haarlem : Merck Sharp & Dohme B.V.
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Heerlen : 1200.75.31006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Leiden : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leiden : 1200.131.03153 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Maastricht : 1200.75.31005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Maastricht : Universitair Medisch Centrum Maastricht
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Nijmegen :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Nijmegen : Radboud University Medical Centre Nijmegen
Imaging Colo-Rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging
Nijmegen : Investigational Site Number 528001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Nijmegen : Site Reference ID/Investigator# 44803
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Rotterdam : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Rotterdam : 1300.2.31001 Boehringer Ingelheim Investigational Site
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
Rotterdam : Novartis Investigative Site
A Study of Oral LGK974 in Patients With Melanoma and Lobular Breast Cancer
Rotterdam : Ikazia Ziekenhuis
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Rotterdam : 1200.75.31007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rotterdam : 1200.131.03151 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Rotterdam : Investigational Site Number 528001 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Rotterdam :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Rotterdam : Site Reference ID/Investigator# 44802
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sittard-Geleen : 1200.75.31001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Utrecht : Novartis Investigative Site
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Utrecht :
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Patients With Metastatic and/or Locally Advanced Malignant HER3-Positive Solid Tumors
Utrecht : Novartis Investigative Site
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Utrecht : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Utrecht : Universitair Medisch Centrum
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Utrecht : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Utrecht : Novartis Investigative Site
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
Veldhoven : Maxima Medisch Centrum
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Venlo : VieCuri MC
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
Winterswijk : Streekziekenhuis Koningin Beatrix
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
New Zealand
Auckland : Merck Sharp & Dohme (New Zealand) Ltd.,
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Auckland : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Norway
Drammen : MSD (Norge) AS
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Larvik : Fritzøe klinikk
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Oslo : The Norwegian Radium Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Oslo : 1200.123.4701 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Oslo : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
View More »
Trondheim : Medicus
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Trondheim : 1200.123.4702 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Peru
Callao : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Cusco : 1200.75.51004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lima : 1200.75.51005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lima : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Miraflores : 1200.75.51002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Piura : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
San Isidro : 1200.75.51001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Surquillo : Merck Sharp & Dohme, Peru S.R.L.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Philippines
Cavite : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Cebu : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Davao City : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Iloilo City : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Laguna : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
View More »
Las Pinas City : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Lipa City : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Los Banos, Laguna : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Makati City : Merck Sharp & Dohme (I.A.) Corporation
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Makati City : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Manila : Investigational Site Number 608001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Pasay City : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Quezon City : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Quezon City : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Poland
Bialystok : 1200.75.48002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bialystok : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Bielsko-Biala :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bydgoszcz : Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Bytom : 1200.75.48006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Elblag : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Gdansk : Uniwersyteckie Centrum Kliniczne
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Gdansk :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Gdansk : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gdansk : 1200.75.48003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Gdansk : Akademickie Centrum Kliniczne Szpital Akademii Medycznej w Gdansku
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Gdansk :
Sorafenib Long Term Extension Program (STEP)
Gdańsk : Uniwersyteckie Centrum Kliniczne Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Gdańsk : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Gdynia : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Gliwice :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Konin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Krakow : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Krakow : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Lodz : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Lodz : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lodz : 1200.75.48004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lublin : III Oddzial Onkologii Ginekologicznej
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Lublin : 1200.75.48007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lublin : Samodzielny Publiczny Szpital Kliniczny nr 4
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Olsztyn : Zaklad Opieki Zdrowotnej MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Olsztyn : 1200.75.48001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Olsztyn : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Otwock : NZOZ Europejskie Centrum Zdrowia Otwock
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Poznan : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Poznan : Klinika Onkologii AM w Poznaniu
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Poznan : Oddzial Radioterapii
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Poznan : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poznan :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Poznan : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Poznan : Wielkopolskie Centrum Pulmunologii i Torakochirurgii
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Poznan :
Sorafenib Long Term Extension Program (STEP)
Prabuty : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Rzeszow : 1200.75.48012 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Szczecin :
Sorafenib Long Term Extension Program (STEP)
Szczecin : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Warsaw : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Warsaw :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Warsaw : 1200.75.48010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Warsaw : Centrum Onkologii - Instytut im.Marii Sklodowskiej-Curie
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Warszawa : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Warszawa : Centrum Onkologii Instytut im. M. Sklodowskiej-Curie
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Warszawa : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Warszawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Warszawa :
Sorafenib Long Term Extension Program (STEP)
Warszawa : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Warszawa : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Wloclawek : Pfizer Investigational Site
Open Label Extension In Cancer Patients
Wroclaw : Wojewódzki Szpital Specjalistyczny we Wrocławiu Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Wroclaw : Dolnoslaskie Centrum Chorob Pluc
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Wroclaw :
Sorafenib Long Term Extension Program (STEP)
Portugal
Almada : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Almada : GSK Investigational Site
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Barreiro : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Coimbra : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Coimbra : 1200.75.35102 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Coimbra : 1200.75.35104 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Coimbra : Investigational Site Number 620005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Évora : 1200.75.35107 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lisboa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lisboa : 1200.75.35109 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lisboa : 1200.75.35101 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lisboa : Investigational Site Number 620004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Lisboa : Investigational Site Number 620001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Lisboa : GSK Investigational Site
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Porto : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto : 1200.75.35103 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Porto : Investigational Site Number 620003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Porto : GSK Investigational Site
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Setúbal : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Vila Real : 1200.75.35105 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Puerto Rico
Ponce : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Juan : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Romania
Braila :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Brasov : Investigational Site Number 642003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bucharest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Bucharest : Societatea Civila Medicala Dinu Uromedica
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Bucharest : Institutul Fundeni
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
View More »
Bucharest : Spitalul Clinic
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Bucharest : Investigational Site Number 642001
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Bucharest : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bucharest : Investigator 2
Tapentadol in Chronic Malignant Tumour Related
Bucuresti : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Bucuresti :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bucuresti : Investigational Site Number 642002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bucuresti : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Cluj - Napoca : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Cluj Napoca : Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Cluj Napoca : Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Cluj Napoca : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cluj-Napoca : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Cluj-Napoca : Investigational Site Number 642002
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Cluj-Napoca : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cluj-Napoca : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Craiova :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Craiova : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Dambovita : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Iasi : Oncology Medical Centre SCM
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Mures : Clinical Caunty Hospital Mures
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Sibiu : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sibiu : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Suceava :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Suceava : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Timisoara : Investigational Site Number 642003
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Timisoara : Investigational Site Number 642001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Russian Federation
Arkhangelsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Arkhangelsk : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Barnaul : Altay Regional Oncology Dispensary
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Barnaul : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Barnaul : 1200.75.07010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Belgorod : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Chelyabinsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Chelyabinsk : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ekaterinburg : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Ekaterinburg : 1200.75.07004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ivanovo : State Institution of Healthcare Ivanovo Regional Oncology Dispensary
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Izhevsk : Budzhet Clinical Oncology Center
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Kazan : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Kazan : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Kazan : 1200.75.07006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Kazan : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Krasnoyarsk : Krasnoyarsk State Medical University Oncology and Radiotherapy Territorial Dispensary
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Lening : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Moscow : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Moscow : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Moscow : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Moscow : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Moscow : 1200.75.07007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Moscow : 1200.75.07008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Moscow : 1200.98.07004 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Moscow : 1200.98.07007 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Moscow : Investigational Site Number 643001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Moscow : Russian Scientific Haematology Centre
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Moscow : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Moscow : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Moscow N/A : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Nizhny Novgorod : 1200.75.07005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Obninsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Omsk : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Orenburg : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Perm : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Petersburg : City Hospital # 2
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Petrozavodsk : Investigational Site Number 643008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Pyatigorsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Pyatigorsk : 1200.98.07012 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Ryazan : 1200.75.07011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Saint Petersburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Saint Petersburg : 1200.75.07001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Saint Petersburg : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Saint-Petersburg : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Saint-Petersburg : State Pavlov Medical University
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Saint-Petersburg : Federal State Institution "Federal Centre of Heart, Blood and Endocrinology of Rosmedtechnologies named after V.A. Almazov"
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Saint-Petersburg : Federal State Institution Russian Scientific-research Institute of Hematology and Transfusiology of Federal Medical-Biological Agency of Russia
Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
Saint-Petersburg : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Samara : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Samara : 1200.98.07008 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Smolensk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Sochi : 1200.98.07011 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Sochi : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
St Petersburg : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
St Petersburg N/A : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
St. Petersburg : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
St. Petersburg : 1200.75.07002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
St. Petersburg : 1200.75.07003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
St. Petersburg : 1200.75.07009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
St. Petersburg : 1200.98.07002 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
St. Petersburg : 1200.98.07010 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
St. Petersburg : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
St.-Petersburg : Investigational Site Number 643005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Stavropol : Research Site
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Stavropol : 1200.98.07003 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
St-Petersburg : Investigational Site Number 643004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Tula : 1200.98.07005 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Tver : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Ufa : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Volgograd : Investigational Site Number 643007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Voronezh : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Yaroslavl : 1200.98.07006 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Serbia
Belgrade : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Belgrade : Klinicko-bolnicki centar Bezanijska kosa
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Belgrade : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Nis : Klinicki Centar Nis
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Sremska Kamenica : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Sremska Kamenica : Institute for pulmonary disease Sremska Kamenica
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Sremska Kamenica : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Singapore
Singapore : Merck Sharp & Dohme (Singapore)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Singapore : 1200.75.65001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Singapore : 1200.75.65002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Singapore : 1200.75.65003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Singapore : 1200.123.6501 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
View More »
Singapore : National University Hospital (s) PTE LTD.
Open-label, Non-randomized, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
Singapore :
Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors
Singapore : Investigational Site Number 702001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Singapore : Investigational Site Number 702002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Singapore : National Cancer Center Singapore
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
Singapore : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Singapore : GSK Investigational Site
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Tiong Bahru : National Cancer Centre
A Study of Alisertib (MLN8237) in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas
Slovakia
Bardejov : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bratislava : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Bratislava : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bratislava 2 : Merck, Sharp & Dohme
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Kosice : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Martin : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Nitra : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poprad : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Zilina : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Slovenia
Ljubljana : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ljubljana : 1200.75.38601 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Sempeter pri Gorici : 1200.75.38602 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
South Africa
Cape Town : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Cape Town : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Durban : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Johannesburg : 1200.75.27001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Johannesburg : 1200.75.27006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Johannesburg : Investigational Site Number 710003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Johannesburg : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Kraaifontein : 1200.75.27004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Midrand : MSD (Pty) LTD South Africa
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Morningside, Johannesburg : 1200.75.27009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Parktown : Investigational Site Number 710002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Port Elizabeth : 1200.75.27005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Port Elizabeth : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Pretoria : 1200.75.27003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Pretoria : 1200.43.02702 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Pretoria : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Prinshoff, Pretoria : 1200.75.27010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rondebosch : 1200.75.27008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Spain
A Coruña : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
A Coruna : Centro Oncológico Regional de Galicia
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Alicante :
Sorafenib Long Term Extension Program (STEP)
Badalona : Hospital Germans Tries i Pujol
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Badalona : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Badalona : Investigational Site Number 724004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Badalona : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Badalona : Investigational Site Number 724004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Barcelona : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Barcelona :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Barcelona : Hospital Clinic I Provincial de Barcelona
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Barcelona : Hospital Vall d´Hebrón
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Barcelona : Hospital del Mar
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Barcelona : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Barcelona : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Barcelona : Novartis Investigative Site
A Study of Oral LGK974 in Patients With Melanoma and Lobular Breast Cancer
Barcelona :
A Study of RO5212054 (PLX3603) in Patients With BRAF V600-mutated Advanced Solid Tumours
Barcelona :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
Barcelona : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Barcelona : 1199.119.34001 Boehringer Ingelheim Investigational Site
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Barcelona : 1199.119.34002 Boehringer Ingelheim Investigational Site
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Barcelona : H. de la Santa Creu I Sant Pau
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Barcelona : H. del Mar / H. de la Esperanza
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Barcelona :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Barcelona : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Barcelona : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Barcelona : 1200.75.34011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Barcelona : 1200.75.34001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Barcelona : 1200.75.34002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Barcelona : 1200.67.34002 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Barcelona : 1200.43.03401 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Barcelona : 1200.43.03404 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Barcelona : 1200.131.03451 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Barcelona : 1200.131.03453 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Barcelona : 1200.131.03454 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Barcelona : Investigational Site Number 724001 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Barcelona : Investigational Site Number 724001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Barcelona : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Barcelona : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Barcelona :
Sorafenib Long Term Extension Program (STEP)
Barcelona : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Barcelona : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Barcelona : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Barcelona : Investigational Site Number 724001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Barcelona : ACROSS
XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
El Palmar : H.U. Virgen de la Arrixaca
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Elche : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Girona : H. Josep Trueta (ICO)
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Girona : 1200.43.03405 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Granada : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Hospitalet De Llobregat : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Hospitalet de Llobregat : Institut Catala Oncologia: Hospital Duran y Reynals
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Hospitalet de Llobregat : 1200.131.03452 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Las Palmas de Gran Canaria : H. G. Doctor Negrín
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Las Palmas de Gran Canaria : 1200.75.34004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
L'Hospitalet de Llobregat : 1199.119.34003 Boehringer Ingelheim Investigational Site
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
L'Hospitalet de Llobregat : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Madrid : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Madrid : Novartis Investigative Site
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Madrid :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated
A Study for Patients With Pancreatic Cancer
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Madrid : H. Ramón y Cajal
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Madrid : Fundación Jiménez Díaz
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Madrid : H. Gregorio Marañón
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Madrid : Clinica Ruber Internacional
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Madrid : Investigational Site Number 724001
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
Madrid : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Madrid : 1200.75.34010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Madrid : 1200.75.34007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Madrid : 1200.67.34003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Madrid : 1200.131.03457 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Madrid : 1200.123.3402 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Madrid : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Madrid : Investigational Site Number 724002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Madrid :
Sorafenib Long Term Extension Program (STEP)
Madrid : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Madrid : Investigational Site Number 724003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Malaga : Complejo Hospitalario Virgen de la Victoria
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Malaga : H. Carlos Haya
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Malaga : 1200.123.3404 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Málaga : 1200.43.03406 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Málaga : 1200.131.03456 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Murcia : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Oviedo :
Sorafenib Long Term Extension Program (STEP)
Palma de Mallorca : 1200.75.34003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Pamplona : Hospital de Navarra
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Pamplona : 1200.131.03455 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Salamanca : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Salamanca : 1200.43.03402 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Sanchinarro :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Santa Cruz de Tenerife : H. U. de Canarias
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Santander : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santander : 1200.123.3403 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Santiago : H.U. de Santiago
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Sevilla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Sevilla : 1200.123.3401 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Toledo : 1200.75.34005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Valencia : Instituto Valenciano de Oncología-Fundación (IVO-FINCIVO)
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Valencia :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Valencia : 1200.75.34008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Valencia : 1200.67.34004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Valencia : 1200.67.34001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Valencia :
Sorafenib Long Term Extension Program (STEP)
Valencia : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Valencia : Investigational Site Number 724002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Vigo : H. do Meixoeiro
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Zaragoza : 1200.43.03403 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Zaragoza : 1200.131.03458 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Sri Lanka
Maharagama : 1200.75.94001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Sweden
Eskilstuna : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linkoping : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Linköping : 1200.123.4602 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Lund : Oncology clinic, Skånes Universitetssjukhus i Lund
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
View More »
Lund : Novartis Investigative Site
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Solna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Stockholm : Urology clinic, Södersjukhuset AB
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Stockholm : 1200.43.04601 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Stockholm : 1200.123.4604 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Stockholm : Novartis Investigative Site
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Stockholm : Investigational Site Number 752001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Uddevalla : Investigational Site Number 752002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Umeå : Oncology clinic, Norrlands Universitetssjukhus
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Uppsala : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Switzerland
Basel : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bellinzona : GSK Investigational Site
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Bellinzona : Ospedale San Giovanni
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Bellinzona : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Bellinzona : Research Site Updated
Phase I Comparative Bioavailability Study
View More »
Geneva 14 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lausanne : GSK Investigational Site
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
St Gallen : GSK Investigational Site
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
St. Gallen : Novartis Investigative Site
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
St-Gallen : Novartis Investigative Site
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Winterthur : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Zürich : Novartis Investigative Site
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Zürich : Novartis Investigative Site
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Taiwan
Changhua : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Changhua : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Changhua : 1200.75.88607 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Gueishan Township : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kaohsiung : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
View More »
Kaohsiung : 1200.75.88604 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Kaohsiung : 1200.75.88608 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Many Locations :
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Niaosong Township : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taichung : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Taichung : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Taichung : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Taichung : 1200.75.88602 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Taichung : 1200.98.88603 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Tainan : National Cheng Kung University Hospital
A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Tainan : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Tainan : 1200.75.88609 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Tainan : 1200.98.88606 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Taipei : Pfizer Investigational Site
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Taipei : Merck Sharp & Dohme (I.A.) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Taipei : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Taipei : Taipei Mackay Memorial Hospital
Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer
Taipei : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Taipei : 1200.75.88603 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Taipei : 1200.75.88610 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Taipei : 1200.75.88606 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Taipei : 1200.75.88601 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Taipei : 1200.98.88605 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Taipei : 1200.98.88601 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Taipei : 1200.98.88602 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Taipei : 1200.98.88604 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Taipei : 1280.1.88601 Boehringer Ingelheim Investigational Site
Phase I Trial of BI 836845 for Various Solid Cancer
Taipei :
Sorafenib Long Term Extension Program (STEP)
Taipei : Novartis Investigative Site
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Taipei City : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taoyuan County : 1200.75.88605 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Thailand
Bangkok : MSD (Thailand) Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Bangkok : 1200.89.66002 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Bangkok : 1200.89.66004 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Bangkok : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Bangkok : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
View More »
Bangkok : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Chiangmai : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Hat-Yai, Songkhla : 1200.89.66001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Songkla : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Ukraine
Dnepropetrovsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Dnipropetrovsk : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Donetsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Ivano-Francovsk : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Kiev : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
View More »
Kiev :
Sorafenib Long Term Extension Program (STEP)
Lviv : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Lviv : Pfizer Investigational Site
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Odessa : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Uzhgorod : Updated
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Uzhgorod : GSK Investigational Site Updated
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
United Kingdom
Aberdeen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Aberdeen : 1200.123.4401 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Bebington : 1200.98.44003 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Bebington, Wirral : Clatterbridge Centre for Oncology
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Belfast : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Belfast : Investigational Site Number 826006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Belfast : Investigational Site Number 826001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Birmingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Birmingham : Investigational Site Number 826011
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Birmingham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Birmingham : 1200.123.4406 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Birmingham : Investigational Site Number 826003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Birmingham : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Birmingham : Investigational Site Number 826006 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Bournemouth : 1200.89.44002 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Bournemouth : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Bournemouth : 1200.98.44001 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Bournemouth : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Brighton : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Bristol :
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Bury :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bury St. Edmunds :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Cambridge : Investigational Site Number 826001 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Cardiff :
Sorafenib Long Term Extension Program (STEP)
Chelmsford : 1200.98.44002 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Chester : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Cottingham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Coventry : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Coventry : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Crumpsall :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Crumpsall : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Derby : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Dundee : Ninewells Hospital and Medical School
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Edinburgh :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Edinburgh : 1200.75.44003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Edinburgh : 1200.131.04455 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Edinburgh : Novartis Investigative Site
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Edinburgh : Research Site Updated
Phase I Comparative Bioavailability Study
Edinburgh : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Edinburgh : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Exeter : 1200.98.44004 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Glasgow : Investigational Site Number 826003
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Glasgow :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Glasgow : The Beatson West of Scotland Cancer Centre
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Glasgow : Investigational Site Number 826002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Glasgow :
Sorafenib Long Term Extension Program (STEP)
Glasgow : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Gorleston on Sea :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Guildford : 1200.123.4405 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
High Heaton : Novartis Investigative Site Updated
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Hoddesdon : Merck Sharp & Dohme Ltd.
A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)
Hoddesdon : Merck Sharp & Dohme Ltd.
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
Hoddesdon : Merck Sharp & Dohme Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hoddesdon : Merck Sharp & Dohme Ltd.
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Hoddesdon : Merck Sharp & Dohme Ltd.
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)
Huddersfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Inverness : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Leeds :
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
Leeds : Investigational Site Number 826013
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Leeds : Investigational Site Number 826004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Leeds : Investigational Site Number 826007 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Leeds : 1280.2.4402 Boehringer Ingelheim Investigational Site
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours
Leicester : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leicester : 1200.131.04453 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Leicester : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Liverpool : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
London : Royal Marsden Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
London : University College Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
London : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
London : St. Georges Hospital NHS Trust
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
London : Guy's Hospital
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
London : University College London Cancer Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
London : 1200.89.44001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
London : University College London Hospitals NHS Foundation Trust
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
London : 1200.75.44001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
London : 1200.98.44005 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
London : 1200.131.04451 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
London : Investigational Site Number 826001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
London : Guy's Hospital
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
London : Investigational Site Number 826001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
London : Investigational Site Number 826005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
London : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
London :
Sorafenib Long Term Extension Program (STEP)
London : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
London : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
London : Investigator Sites
Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors
London : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
London : Investigational Site Number 826003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
London : Investigational Site Number 826004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
London : 1200.12.4402 Boehringer Ingelheim Investigational Site
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Maidstone : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Maidstone :
Sorafenib Long Term Extension Program (STEP)
Manchester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Manchester : The Christie NHS Foundation Trust
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
Manchester : Investigational Site Number 826012
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Manchester : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Manchester : GSK Investigational Site
Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
Manchester : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Manchester : 1200.131.04452 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Manchester : Research Site Updated
Phase I Comparative Bioavailability Study
Manchester : Investigational Site Number 826007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Manchester : Research Site
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Manchester : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Manchester : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Manchester : Research Site
Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014
Middlesbrough : 1200.98.44006 Boehringer Ingelheim Investigational Site
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Newcastle : Research Facility Updated
Phase I Comparative Bioavailability Study
Newcastle Upon Tyne : Investigational Site Number 826002 Updated
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Newcastle Upon Tyne : Sir Bobby Robson Cancer Trials Research Centre
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Newcastle Upon Tyne : Investigational Site Number 826008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Norfolk : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
North Cheam : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Northampton : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Northwood : Mount Vernon Cancer Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Northwood : Research Site Updated
Phase I Comparative Bioavailability Study
Northwood : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Norwich :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Nottingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Nonsmall Cell Lung Cancer
Nottingham : Investigational Site Number 826005
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Nottingham : Nottingham Urology Centre, NHS Trust Updated
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Nottingham : GSK Investigational Site Updated
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Nottingham : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Oxford : Novartis Investigative Site
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Oxford : Churchill Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oxford : Research Site Updated
Phase I Comparative Bioavailability Study
Oxford : Investigational Site Number 826009 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Plymouth :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Plymouth : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Preston : Investigational Site Number 826008
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Sheffield : 1200.131.04454 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Sheffield : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Southampton : Investigational Site Number 826010 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Southampton :
Sorafenib Long Term Extension Program (STEP)
Surrey : Updated
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Surrey : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Sutton : Institute of Cancer Research, Royal Marsden Hospital
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Sutton : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Sutton : Drug Development Unit Royal Mardsen NHS Foundation Trust
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Sutton : Investigational Site Number 826001
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Sutton : Research Site Updated
Phase I Comparative Bioavailability Study
Sutton : Research Site
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Sutton :
Sorafenib Long Term Extension Program (STEP)
Sutton : GSK Investigational Site
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Sutton : Royal Marsden Hospital
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Sutton : Royal Marsden Hospital Updated
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Sutton : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Sutton : Royal Mardsen Hospital
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Sutton : Research Site
Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014
Sutton : 1200.12.4401 Boehringer Ingelheim Investigational Site
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Sutton : 1280.2.4401 Boehringer Ingelheim Investigational Site
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours
Taunton : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Tooting : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Torquay : Investigational Site Number 826007
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Weston Super Mare :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Wirral : Investigational Site Number 826004
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Withington, Manchester :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Wolverhampton :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Wolverhampton : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Woolwich, London : 1200.75.44005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wythenshawe, Manchester : Research Site
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
United States
Washington : Research Site Updated
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Washington : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Washington : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Washington : Research Site
Panitumumab Pediatric Study
Washington : Investigational Site Number 840020 Updated
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment